Вы находитесь на странице: 1из 56

The Course programme Faculty interviews Abstract posters Exhibit guide Words from the industry partners and

more...

Programme

16th-18th January, 2014 - Singapore


15th January, 2014 - Practical PCI Pre-Course

EDITORIAL

Editorial
Dear Friends,
We offer a warm welcome to all of you attending AsiaPCR/ SingLIVE 2014, our 5th session of this increasingly dynamic world-class Course. With the experience of our Asian and international colleagues, the dedication of our Faculty and Programme Committee Members and the incredible resources of the PCR Family we are proud to present a Course that is designed By & For you, offering the very best in practical information and education. For those who participated in the Practical PCI Course that took place the day before AsiaPCR/SingLIVE 2014 began, you already have an idea of what to expect during the next few days that we will spend together. The 2014 programme will continue to highlight new stent developments and techniques. We will share the expertise of specialists from India, China and Thailand, through LIVE transmissions in the state-of-the-art treatment of left main, CTOs, bifurcations and transradial procedures. We are especially excited about new aspects of this years programme that include the increasing collaboration between regional PCI communities, encouraging the active cross border exchange of knowledge and learning. There will be sessions showcasing complications from 5 different countries; individual programme segments emphasising structural heart interventions using MitraClip, TAVI and LAA; ongoing discussions between world experts on the latest developments in renal denervation; and a totally new track created by PCR Familys renown Educative Solutions Research Group offering fresh perspectives and new levels of interactivity to the Course. We cordially invite you to our very special Lunch with the Course Directors. A unique platform for the exchange of practical pointers, allowing for the direct and informal interaction between Course Directors and participants.

Welcome home!
AsiaPCR/SingLIVE 2014 is the first of the PCR family Courses of the Year. This Course has established itself as a unique forum for expression of the interventional community, hosted by our colleagues from Asia-Pacic region. The impact of research, innovation and clinical expertise from the region has become essential to the progress of interventional medicine worldwide. At the same time, the Course recognises specic needs and demands of participants to AsiaPCR/SingLIVE. This is reected in this years programme, with some new features, sessions that are unique to Asia, and a growing emphasis on interactive Learning sessions. The educational experience will start with another edition of the successful Practical PCI PreCourse, focusing on practical aspects of coronary intervention, as relevant to the region at large. The PCR community needs your input and evaluation in order to continuously improve AsiaPCR/SingLIVE and other PCR Courses alike. Please pay careful attention to the LIVE demonstrations. The broadcasting teams and session chairs have worked hard to try and improve on their educational content. We aim at maximising the added value for your practice and at increasing your interaction, either during or after case completion, such that any question you may have shall be addressed. New this year, you are all invited to join an informal lunch discussion on Saturday 18th January from 12:00 in the exhibition area. This will be a unique opportunity to share your feedback, to raise yet unanswered questions or to provide suggestions to Course Directors and Programme Committee Members, highlighting what went well, and what can be further improved. Enjoy the exchange of knowledge and experience: we have so much to learn from each other, all for the benet of patient care and well being!

Tian-Hai Koh Course Director

Eric Eeckhout Course Director

William Wijns Chairman of PCR

AsiaPCR/SingLIVE 2014 - Programme 2

BOARD MEMBERS

Directors & Co-Directors


Course Directors Course Co-Directors

Tian Hai Koh SINGAPORE

Jean Fajadet FRANCE

Junbo Ge CHINA

Soo Teik Lim SINGAPORE

Marie-Claude Morice FRANCE

Christoph K. Naber GERMANY

Eric Eeckhout SWITZERLAND

Shigeru Saito
JAPAN

Patrick W. Serruys THE NETHERLANDS

Aaron Wong SINGAPORE

Programme Committee Members


Takashi Akasaka, JAPAN Siro Buendia, SPAIN Praveen Chandra, INDIA Jun-Jack Cheng, TAIWAN Paul Chiam, SINGAPORE Chee-Tang Chin, SINGAPORE Giulio Guagliumi, ITALIA Kentaro Hayashida, JAPAN Myeong-Ki Hong, SOUTH KOREA Veronica Kwok, SINGAPORE Michael Lee, HONG KONG Felix Mahfoud, GERMANY Hung Pham Manh, VIET NAM Sundeep Mishra, INDIA Rosil Mohd Ali, MALAYSIA Ngoc Quang Nguyen, VIET NAM Marko Noc, SLOVENIA Siddhart Radhakrishnan, INDIA Sharad Shetty, AUSTRALIA Sunarya Soerianata, INDONESIA Satoru Sumitsuji, VIET NAM Jack Tan, SINGAPORE Ju Le Tan, SINGAPORE Wasan Udayachalerm, THAILAND Wan Ahmad Wan Azman, MALAYSIA Chiung-Jen Wu, TAIWAN Khung Keong Yeo, SINGAPORE Robaayah Zambahari, MALAYSIA Bin Zhang, CHINA

AsiaPCR/SingLIVE 2014 - Programme 3

GUEST FACULTY

Our sincere thanks to the Guest Faculty


Aaron Wong, SINGAPORE Abdul Wahab Bin Undok, MALAYSIA Achmad Fauzi Yahya, INDONESIA Adrian Low, SINGAPORE Afzalur Rahman, BANGLADESH Ajit Menon, INDIA Aman Salwan, INDIA Andrew Ong, AUSTRALIA Ani Yearoo, MAURITIUS Antonia Anna Lukito, INDONESIA Arthur Tan, SINGAPORE Asha Mahilmaran, INDIA Ashok Seth, INDIA Ashwin Mehta, INDIA Benjamin Chua, SINGAPORE Bernard Chevalier, FRANCE Bin Zhang, CHINA Brian Khoo, SINGAPORE Bruno Farah, FRANCE Bruno Garcia Del Blanco, SPAIN Budi Baktijasa Darmadjati, INDONESIA Burdi Yuli Setianto, INDONESIA Carlo Briguori, ITALY Chee Tang Chin, SINGAPORE Cheng-I Cheng, TAIWAN Chi Hung Huang, TAIWAN Chia-Yu Chou, TAIWAN Chiang Soo Tan, MALAYSIA Chih-Kuan Liao, TAIWAN Chinniah Saraswathy, SINGAPORE Chiung-Jen Wu, TAIWAN Chong-Hiok Tan, SINGAPORE Choong Meng Chan, SINGAPORE Chris Kwok Yiu Wong, HONG KONG Christoph K. Naber, GERMANY Chun-Ming Shih, TAIWAN Damras Tresukosol, THAILAND David Wong, USA Debasis Ghosh, INDIA Debdatta Bhattacharya, INDIA Derek Yong, SINGAPORE Dick Chi Yeung Cheung, HONG KONG Didier Tchtch, FRANCE Dinh D Huy, VIET NAM Doni Firman, INDONESIA Eberhard Grube, GERMANY Eric Eeckhout, SWITZERLAND Eric Chi Yuen Wong, HONG KONG Etsuo Tsuchikane, JAPAN Evgeniy Merkulov, RUSSIAN FEDERATION Fabio Enrique Posas, PHILIPPINES Fahim H Jafary, SINGAPORE Faizal Ali, INDIA Fazila Malik, BANGLADESH Felix Mahfoud, GERMANY Feng-Yu Kuo, TAIWAN Fuminobu Yoshimachi, JAPAN G. Sengottuvelu, INDIA Gary Cheung, HONG KONG Gerald Yong, AUSTRALIA Gim-Hooi Choo, MALAYSIA Giulio Guagliumi, ITALY Giuseppe De Luca, ITALY Gokul Reddy Mandala, INDIA Hana Trisnohadi, INDONESIA Harry Suryapranata, THE NETHERLANDS Hee Hwa Ho, SINGAPORE Ho Thuong Dung, VIET NAM Hsiu Yu Fang, TAIWAN Huay Cheem Tan, SINGAPORE Hyeon-Cheol Gwon, SOUTH KOREA Ib Vijayalakshmi, INDIA In-Ho Chae, SOUTH KOREA Jack Tan, SINGAPORE Jacques Berland, FRANCE Jacques Monsegu, FRANCE Jagdish S Hiremath, INDIA James Yip, SINGAPORE Jason Loh, SINGAPORE Jaspal Arneja, INDIA Jean Fajadet, FRANCE Jia Lin Soon, SINGAPORE Jiang Ming Fam, SINGAPORE Joo-Yong Han, SOUTH KOREA Jose Maria De La Torre Hernandez, SPAIN Ju Le Tan, SINGAPORE Juan F. Iglesias, SWITZERLAND Julian Ko-Beng Tan, SINGAPORE Jun-Jack Cheng, TAIWAN Junbo Ge, CHINA Junko Honye, JAPAN Kam-Tim Chan, HONG KONG Kang Cheng, CHINA Kay-Woon Ho, SINGAPORE Keith G. Oldroyd, UNITED KINGDOM Kentaro Hayashida, JAPAN Kevin Yau Tung Wai, HONG KONG Khang-Leng Leow, SINGAPORE Khe-Sui, James Ho, PHILIPPINES Khung Keong Yeo, SINGAPORE Kiang Hiong Tay, SINGAPORE Kok Han Chee, MALAYSIA Kui-Hian Sim, MALAYSIA Kyo Eisho, JAPAN Lam Ho, HONG KONG Latchumanadhas Kalidoss, INDIA Lee Yian Ping, SINGAPORE Leslie Lam, SINGAPORE Leslie Tay, SINGAPORE Limpijankit Thosaphol, THAILAND Linda Lison, INDONESIA Lip Ping Low, SINGAPORE Luc Bilodeau, CANADA M Nasir Muda, MALAYSIA Man Hong Jim, HONG KONG Manh-Hung Pham, VIET NAM Manish Taneja, SINGAPORE Manoj Kumar, INDIA Marc Bedossa, FRANCE Marie-Claude Morice, FRANCE Mark Chan, SINGAPORE Mark Rosenberg, GERMANY Marko Noc, SLOVENIA Martyn Thomas, UNITED KINGDOM Masahiko Ochiai, JAPAN Masato Nakamura, JAPAN Mathew Samuel Kalarickal, INDIA Maurice Choo, SINGAPORE Maurizio DAmico, ITALY

AsiaPCR/SingLIVE 2014 - Programme 4

GUEST FACULTY

Mazeni Alwi, MALAYSIA Michael Lim, SINGAPORE Michael Nguyen, AUSTRALIA Michael Kang-Yin Lee, HONG KONG Muhammad Munawar, INDONESIA Muhammad Yamin, INDONESIA Myeong-Ki Hong, SOUTH KOREA N. N. Khanna, INDIA Nagendra Chouhan, INDIA Nakrai Nutcharee, THAILAND Naoto Inoue, JAPAN Nazir Ahmed, BANGLADESH Ngoc-Quang Nguyen, VIET NAM Nicolas Foin, SINGAPORE Nwe Nwe, MYANMAR Olivier Varenne, FRANCE Oteh Maskon, MALAYSIA Partha Sarathi Banerjere, INDIA Patrick W. Serruys, THE NETHERLANDS Paul Chiam, SINGAPORE Paul Jau Lueng Ong, SINGAPORE Peter Yan, SINGAPORE Philip Koh, SINGAPORE Philip Wong, SINGAPORE Pintoko Tedjokusumo , INDONESIA Po-Ming Ku, TAIWAN Prakas Chandra Mondal, INDIA Praveen Chandra, INDIA Praveer Agarwal, INDIA Pravin Kumar Goel, INDIA Quang Huan Do, VIET NAM Quang-Tuan Nguyen, VIET NAM Rabindra Nath Chakraborty, INDIA Rajeeve Kumar, INDIA Rajpal K Abhaichand, INDIA Ravinay Bhindi, AUSTRALIA Reginald Low, USA Richard Ng, SINGAPORE Robaayah Zambahari, MALAYSIA Robert-Jan Van Geuns, THE NETHERLANDS Rogelio Tangco, PHILIPPINES Ronald Chi-Hang Lee, SINGAPORE Rosil Mohd Ali, MALAYSIA Sajidah Khan, SOUTH AFRICA

Satoru Sumitsuji, JAPAN Scott Harding, NEW ZEALAND See-Hooi Ewe, SINGAPORE Selvanayagi Sundrasenan, MALAYSIA Seung-Ho Hur, SOUTH KOREA Seung-Jung Park, SOUTH KOREA Seung-Woon Rha, SOUTH KOREA Shao-Liang Chen, CHINA Sharad V Shetty, AUSTRALIA Shigeru Saito, JAPAN Shozo Ishihara, JAPAN Simon Redwood, UNITED KINGDOM Siro Buendia, SPAIN Sitaraman Radhakrishnan, INDIA Sivakumar Rathnavel, INDIA Sodiqur Rifqi, INDONESIA Soe-Win Kyaw, MYANMAR Sok Chour, CAMBODIA Soo Teik Lim, SINGAPORE Sreenivas Kumar Arramraju, INDIA Stefan Hardt, GERMANY Stephane Cook, SWITZERLAND Stephen Lee, HONG KONG Subhash Chandra, INDIA Sudipt Chakraborty, HONG KONG Sunao Nakamura, JAPAN Sunarya Soerianata, INDONESIA Sundeep Mishra, INDIA Sung Yun Lee, SOUTH KOREA Suphot Srimahachota, THAILAND Surya Prakasa Rao Vithala, INDIA Swee-Choon Ng, MALAYSIA Tae-Jin Youn, SOUTH KOREA Takashi Akasaka, JAPAN Takehiro Yamashita, JAPAN Tamil Selvan, MALAYSIA Tapan Ghose, INDIA Teguh Santoso, INDONESIA Than Than Kyaing, MYANMAR Thanawat Benjanuwattra, THAILAND Thanh Nhan Vo , VIET NAM Thomas Cuisset, FRANCE Thuong Nghia Nguyen, VIET NAM Tian-Hai Koh, SINGAPORE

Tien-Ping Tsao, TAIWAN Tina Teo, SINGAPORE Tiong Kiam Ong, MALAYSIA Tom Slagboom, THE NETHERLANDS Toon Wei Lim, SINGAPORE Toshiya Muramatsu, JAPAN Upendra Kaul, INDIA Veronica Kwok, SINGAPORE Victor Chao, SINGAPORE Viveka Kumar, INDIA Wacin Buddhari, THAILAND Wah Hak Nien Shen, Charles Chan, SINGAPORE Wan Ahmad Wan Azman, MALAYSIA Wasan Udayachalerm, THAILAND Wen-Yi Guo, CHINA Wijeyasingam Santharaj, SRI LANKA William Hau, HONG KONG William Wijns, BELGIUM Wirash Kehasukcharoen, THAILAND Woo-Young Chung, SOUTH KOREA Ya-Ling Han, CHINA Yean-Teng Lim, SINGAPORE Yong Huo, CHINA Yong Hoon Kim, SOUTH KOREA Yoong-Kong, Kenny Sin, SINGAPORE Yu-Lin Ko, TAIWAN Yudi Her Oktaviono, INDONESIA Yuji Hamazaki, JAPAN Zee-Pin Ding, SINGAPORE

AsiaPCR/SingLIVE 2014 - Programme 5

AsiaIntervention, a dedicated regional issue


The number of interventional procedures continues to rise in most Asian countries, powered by China and India, but also in the ASEAN countries. New cardiac catheterisation laboratories are constantly being set up across the region, and there is an ongoing need for the training of young interventional cardiologists that are needed to sta them. This year, AsiaPCR-SingLIVE Course celebrates its fth edition. The meeting has grown in the number of participants, content and submissions of scientic abstracts and clinical cases. The AsiaPCR/ SingLIVE meeting hence serves to highlight the latest international practices and recommended PCI guidelines from the West, with input by key opinion leaders from Asia. This is critical as practices and expertise vary across dierent regions in Asia. Equally, cultural preferences and genetic make-up of the people in Asia can also vary from the West. Major Asian centres are also embarking on structural heart interventions, and Asian registries of such device based interventions should be helpful in identifying any dierences compared to the Western experience. It is with this in mind that the special issue AsiaIntervention, a new publication dedicated to the cardiovascular interventional eld within the Pacic Rim region, has been created. The aim of the current issue is to highlight the endeavours of APSIC, ASPC and the Chien Foundation in developing further scientic progress within the broad international region. The issues contents are linked also to AsiaPCR/SingLIVE 2014, by publishing the accepted oral abstracts of the meeting including a small selection of the best papers and inviting the participating National Societies at AsiaPCR/SingLIVE 2014 to present their organisations. We hope you enjoy reading AsiaIntervention and look forward to seeing you here during AsiaPCR/SingLIVE 2014. Guest Editors A/Prof. Tian-Hai Koh Prof. Eric Eeckhout Editor-in-Chief Prof. Patrick W. Serruys

Interactive Case Corner!


You are invited to actively participate in the Interactive Case Corner, a place of communication, free from any pressure. Selected presenters will share their most educational cases and the facilitators listed below will stimulate interactivity.

Thursday 16th January


10:30-12:00 - R.K. Abhaichand, B. Chevalier 14:00-14:40 - J. Fajadet, G. Sengottuvelu 14:45-16:00 - J.B. Ge, M.C. Morice 16:15-17:30 - N. Chouhan, W.A. Wan Azman, W. Wijns

Friday 17th January


09:00-10:30 - S. Khan, S. Nakamura 10:45-12:00 - R.N. Chakraborty, S. Khan, S. Nakamura 14:00-14:40 - N. Chouhan, R.l. Low, R. Zambahari 14:45-16:00 - R.I. Low, T. Selvan 16:15-17:30 - B. Chua, N. Khanna, K.K. Yeo

Saturday 18th January


08:30-09:30 - S. Khan, S.C. Ng 09:35-10:35 - S. Khan, S.C. Ng 10:45-11:45 - R.M. Ali, P. Chiam, K. Hayashida

AsiaPCR/SingLIVE 2014 - Programme 6

CHIEN FOUNDATION

Marie-Claude Morice Chien Foundation award for outstanding lectureship & lifetime achievement in PCI
The Chien Foundation is a charitable foundation set up in Singapore 17 years ago, in January 1997, by philanthropist Mr. Teddy Chien and Dr. Richard Ng. It is for the purpose of promoting education, training and research in cardiovascular medicine, focusing on interventional cardiology. The aim is to benet young cardiology doctors in the Asian Pacic region to be trained in fellowship programs in more advanced cardiac centers. Six years ago, the Foundation expanded its programs to include Best Abstract presentations for young investigators in AsiaPacic PCI meetings such as CIT in Beijing/Shanghai China, TCTAP meeting in South Korea and the AsiaPCR-SingLive meeting here. The Chien Foundation has also awarded Chien Foundation Lectureship to honour outstanding teachers, mentors and promoters in education & research in PCI in Asia, Europe, U.S.A. and internationally. So far, the recipients have included Profs./Drs. Eberhard Grube, Alan Yeung, Jean Marco, Patrick W. Serruys, Seung-Jung Park, Harry Suryapranata, Gao Runlin, Martin Leon, Robaayah Zambahari, Richard Ng, Tian-Hai Koh, Jean Fajadet and Shigeru Saito. This year, the Chien Foundation Board of Trustees together with Prof. Tian-Hai Koh of AsiaPCR/SingLIVE 2014 and the National Heart Centre Singapore, have nominated Dr. Marie-Claude Morice from France. She has been a great champion in her lifelong dedication to the practice, promotion and teaching of high standards of PCI. Dr Morices CV is very impressive and we wish to highlight some of it here: Dr Morice graduated from University of Paris VII in 1973 and immediately specialised in cardiology. She started her PCI training with Prof Jean Marco in Toulouse in 1984 and in 1986 was promoted to be Head of PCI or PTCA in Centre Cardiologique du Nord in Paris. In 1995, she was further promoted to be Head of Institute Cardiovascular Paris Sud and co-founded the French study group on Coronary Stenting without Coumadin, and the Indo-French Foundation of Interventional Cardiology. She has participated in all major interventional LIVE meetings in America, Europe, South America, Asia, and has been a lucid and outstanding lecturer and teacher at the Singapore LIVE PCI courses over the many years since inception. Dr. Morice has been active to advance research programs in PCI. Amongst her many research activities are principal investigators of RAVEL, the rst randomised trial on DES; Principal investigator of the Reality study and Co-Principal investigator of the Syntax study. In her current position as Advisor of EuroPCR, she is a very instrumental promoter of joint PCR Courses. Dr. Richard Ng Co-Founder & Senior Trustee Chien Foundation

Thanks to our partners!


^ ABBOTT VASCULAR ^ ALVIMEDICA MEDICAL TECHNOLOGIES ^ ASAHI INTECC CO., LTD ^ B.BRAUN SINGAPORE PTE LTD ^ BALTON ^ BIOSENSORS INTERNATIONAL TECHNOLOGIES PTE LTD ^ BIOTRONIK ^ BOSTON SCIENTIFIC ASIA PACIFIC PTE LTD ^ CENTER FOR EUROPEAN RESEARCH IN CARDIOVASCULAR MEDICINE ^ COVIDIEN ^ EDWARDS LIFESCIENCES ^ GOODMAN CO., LTD AsiaPCR/SingLIVE collaborates with the following organisations: CARDIOVASCULAR SUMMIT-TCTAP 2014 and NHCS ^ HEXACATH SAS ^ INNOHEART ^ KANEKA MEDIX CORPORATION ^ MAQUET SOUTH EAST ASIA PTE LTD ^ MEDTRONIC INTERNATIONAL LTD ^ MINVASYS ^ ORBUSNEICH ^ P.G BOOKS PTE LTD ^ RESEARCHBOOKS ASIA PTE LTD ^ ST JUDE MEDICAL ^ STENTYS ^ TERUMO ASIA HOLDINGS PTE.LTD ^ TRANSMEDIC

Designations used by companies to distinguish their products are often claimed as trademarks. Brand names and product names used in this Programme may be trade names, service marks, trademarks or registered trademarks of their respective owners.

AsiaPCR/SingLIVE 2014 - Programme 7

React@PCR

NEW!
Post instant messages to the chairpersons via your smartphone!
Any questions or comments for the speakers, panellists or operators?
Dont be shy, these anonymous contributions will feed the debate on stage!
Connect to www.reactatpcr.com. Free wi accessible at level 3 and 4. Select the network FREE_WIFI@SuntecSingapore. No password required.

Available in Main Arena

INTERVIEW

An interview with...

Achmad Fauzi Yahya

The Indonesian perspective on managing complications of percutaneous coronary procedures


Achmad Fauzi Yahya Hasan Sadikin hospital, Bandung, Indonesia
Achmad Fauzi Yahya, Hasan Sadikin hospital, Bandung, Indonesia explains why adequate preparation is the key to reducing the risk of complications in patients undergoing coronary interventions. He also reviews the steps that the Indonesia government is taking to ensure all patients in Indonesia receive a high-quality service. g Is there universal provision of care for people requiring coronary interventions in Indonesia? For example, do some people living in remote areas have poor access to care? Indonesiaand almost all other countries around the world have major issues in providing access to healthcare for people living in rural and remote areas. In terms of cardiovascular intervention, the challenge is to ensure that all areas of Indonesia receive a high-quality service. g What steps are being taken to improve provision of care in Indonesia? The Indonesian government is just starting to implement a universal healthcare system, which will cover all Indonesian citizens by 2019. It will take five years to roll out completely, but the idea is that eventually everyone will have access to healthcare that is free at the point of use. The new scheme will cover almost all services, including cardiovascular interventions. Also, the government is working intensely with the private sector and professional bodies such as the Indonesian Society of Interventional Cardiology to overcome the countrys current problems of a shortage of interventional cardiologists and limited cath lab facilities. Therefore, in recent years, the numbers of cath labs have increased in both public and private hospitals. Furthermore, hospitals (private or public) are encouraged to meet certain standard of care if they are to become a centre of interventional cardiology training. We co-operate with neighbouring countries in Asia, and those in Australia and Europe to ensure our interventional cardiology fellows receive the appropriate training. g What are the key risk factors for coronary complications (eg. age, comorbidities) in Indonesia? There are no difference in terms of the key risk factors for coronary complications between the Indonesia population and those of other countries. The risk factors can include comorbiditiesfor example, diabetes, chronic kidney disease, stroke, or left ventricular dysfunctionbut complex lesions (ie. heavy calcification, tortuosity, bifurcation and proximal or ostial lesions) are also notorious for increasing the risk of complications. Modifiable risk factors include operator experience and poorly prepared facilities. At the moment, we are trying to conduct a registry of complications that occur during percutaneous coronary intervention in Indonesian centres across the country. g In Indonesia, in your experience, what are the most common coronary complications? From my perspectivealthough complications are quiet rare nowadaysthe slow/no reflow is the most common complication encountered followed by perforations and trapped devices. g What steps can be taken to prevent these complications? Rigorous preventive measures can reduce the risk of complications. Therefore, it is important to have a fully equipped cath lab. As operators, we have to sharpen our skills and improve our knowledge so that we can truly see the face of our hidden enemy (ie. the complexity of the lesion). We should not forget to adequately prepare the lesion before putting in the stentit is better not to get into trouble in the first place than to try to get out of trouble! g If one of these complications occurs, how should they be managed? If there is a complication, do not ignore it! Some can be managed by simple techniques. But if we do not know how to overcome a complication or we fail to overcome a complication, we should not hesitate to ask for help from other colleagues. g Can you give an example of when you had a complication during a coronary procedure and how you managed it? If I had a coronary perforation, I would perform prolonged inflation at low pressure (46atm for 10 minutes). The covered stent will help if the balloon inflation has failed. Coil material is another tool in our armamentarium to stop the perforation at the distal end of an artery. If sealing is unsuccessful, then reversing the anticoagulation with protamine can work. A few patients need pericardiocentesis. However, we do not do injection of thrombin, gelatin sponge or polyvinyl form to seal the perforation. g What advice would you give to a young interventional cardiologist regarding the preparations they need to make to avoid complications during a procedure? They need to be aware that potentially fatal complications can occur if the operator does not take the time to sit and think about the steps they need to take before undertaking a procedure. Also, they should not rush to do an ad-hoc PCI procedure for complex casesit is important to take the time to evaluate the vessel anatomy and lesions character before deciding the strategy. Also, they should remember to learn from other peoples mistakes!

AsiaPCR/SingLIVE 2014 - Programme 9

INTERVIEW

An interview with...

Andrew Ong

Cardiac catheterisation in practice


Andrew Ong Westmead Hospital, Westmead, Australia
Andrew Ong (Westmead Hospital, Westmead, Australia) provides practical tips for choosing the right catheter for a coronary catheterisation procedure. He also describes the benefits of the radial approach vs. the femoral approach and advises on how to manage complications. g What are the key considerations when choosing a catheter for a cardiac catheterisation procedure? The chosen catheter must be the correct shape to fit the patients anatomy, and also must be the correct size the size will depend on whether the patient is undergoing a diagnostic or interventional procedure. Furthermore, a catheter must adequately opacify the vessel studied and it must provide enough support for the equipment to be used to treat the vessel. g If the results of the angiogram are not clear, would you use an additional diagnostic procedure such as fractional flow reserve (FFR)? If, after diagnostic coronary angiography, there is a question regarding the severity of the lesion and the patient has not undergone a functional test prior to the procedure, then a functional test such as FFR can help to determine whether the lesion requires intervention. Also if there is doubt regarding the anatomical make-up of the lesion, or assessing vessel calcification, then imaging with intravascular ultrasound (IVUS) may be helpful. g When would you use the radial approach and when would you use the femoral approach for a percutaneous coronary intervention (PCI) procedure? The radial approach is my default approach because the complication rate is clearly lower with the radial approach and it is also far more comfortable for the patient. But I would use the femoral approach when there are no radial pulses, if I have to use an 8-French guide catheters (7-French in those with tiny radial arteries), or if I have to insert an intra-aortic balloon pump. g If choosing the transfemoral approach, what steps would you take to reduce the risk of bleeding? The main cause of life-threatening bleeding with the transfemoral approach is a high puncture above the inguinal ligament, which means there is no femoral head to provide counter pressure during manual compression. It is therefore mandatory to check the position of the inguinal ligament relative to the skin or arterial puncture site prior to starting the procedure. I also use a micropuncture kit when the anatomy is tricky or when there is a need to ensure a single puncture. In recent years, some operators have started to routinely use ultrasound to localise their puncture site; however, I find that ultrasound distracts from the procedure. g If choosing the transradial approach, what steps would you take to reduce the risk of radial spasm? Radial artery spasm occurs in 30% of patients. Therefore, I do not routinely use vasodilators [to reduce the risk of radial spasm] as 70% of patients will not have a problem. But for selected patients (eg. young or those with small radial arteries), I use a combination of intra-arterial verapamil and nitroglycerin injected via the radial sheath. I do routinely lightly sedate patients with midazolam and fentanyl to relax them, and that reduces the risk of radial spasm. g If bleeding occurs, how should it be managed? Bleeding is an important complication and must be addressed quickly. Firstly, one must assess the patient to ensure that they are haemodynamically stable; if they are not, one should institute resuscitation procedures to stabilise them. At the same time, the site of bleeding must be identified, and imaging, with a view to an intervention, may need to be performed if local control of the bleeding cannot be achieved. g Aside from bleeding, what other complications can occur during cardiac catheterisation procedures and how can they be prevented? The other major complications, apart from bleeding, that are important are arterial dissection, and stroke. Arterial dissection can be prevented by gently manipulating the equipment through the arterial tree and feeling for any resistance along the way. It is always important to screen the equipment using X-ray guidance when there is any doubt as to how things are progressing. To prevent stroke, it is important to minimise unnecessary manipulation in the arterial tree, to be concise and accurate in the conduct of the cardiac catheterisation procedure. g What are your tips for guiding a catheter through tortuous anatomy? As mentioned above, X-ray guidance is paramount in ensuring that the equipment passes through the arterial tree smoothly. With tortuous anatomy, the use of additional equipment such as a hydrophilic guidewire is useful, as well as the use of a long flexible sheath to protect the catheters from the tortuous anatomy during catheter exchanges. It is important to flush the catheter in cases of tortuosity in case the tip has picked up plaque along the way.

AsiaPCR/SingLIVE 2014 - Programme 10

INTERVIEW

An interview with...

Sunao Nakamura

Choosing the right wire for the job


Sunao Nakamura New Tokyo Hospital, Chiba, Japan
Sunao Nakamura, New Tokyo Hospital, Chiba, Japan, outlines the factors that go into choosing the correct guidewire for a coronary catheterisation procedure and discusses the complications that can occur if the wrong wire is chosen. g How does the lesion type influence your choice of wire? With chronic total occlusions, my choice for the first wire is the Fielder FC as a chronic total occlusion lesion is not always hard and the stiffness of the wire is sufficient to cross the lesion. If the lesion is too hard for the Fielder FC wire, it should be exchanged for a stiffer wire; however before changing the wire, the Corsair microcatheter can be advanced with Fielder FC and also it can explore available channels without causing any injury. g Regardless of the approach used, what are the main factors to consider when choosing a wire for a catheterisation procedure? The trackability to any kind of tortuous vessel is the most important characteristic of the wire. For example with the retrograde approach, the channels are often meandering or corkscrewunless the wire smoothly tracks such winding, the channels will be damaged. Therefore, the wire should be flexible enough to track the vessel anatomy. g What are the potential barriers to choosing the best wire for the job? Both cost and lack of availability are barriers in this respect. g What complications can occur if a wire is incorrectly chosen? An incorrectly chosen wire with the retrograde approach may cause damage to the channel, which may lead to coronary perforation. With the antegrade approach, a wire that is harder than necessary may get into and widen subintima space. If this happens, then a large haematoma could form and compress the collateral channels to cause myocardial ischemia. g What are the latest data for the best retrograde and antegrade wiring techniques? The best techniques have been thoroughly discussed, and we [as interventional cardiologists] have exchanged our experiences with each other at many international conferences. Therefore while there are not any official guidelines for the best techniques, leading interventionist have reached consensus about what these techniques are. g When planning a procedure that involves crossing coronary collaterals, what is the most import factor to consider? The most important factor is to preserve collaterals without causing damage. g What are the optimal characteristics for a wire that will be required to cross collaterals? Trackability of the wire is the most important factor. However, this needs to be achieved without sacrificing flexibility and litheness so that you do not cause damage to the collaterals. Newly developed devicessuch as the Sion guidewire series enable us to track vessels without losing smooth and lithe movement. g What are the challenges of crossing collaterals and how can they be overcome? In the past, the retrograde approach for crossing collaterals was a challenging technique but it has evolved over the past decade. Many good wires and catheters, such as the Corsair microcatheter, have now been developed to overcome these types of challenging anatomy. Therefore, I would say that crossing collaterals is a reasonable challenge but it is not as great a challenge as it used to be. g Do you have any tips or tricks for crossing collaterals? When wire goes into subintima space, it may compress collaterals and this can lead to damage. Therefore, this should be definitely avoided. You need to have a have a good understanding of anatomy of coronary arteries. You should pay the best attention when you advance a wire, which should be done carefully, cautiously and prudently. Be prepared for any possible scenario that you can think of.

AsiaPCR/SingLIVE 2014 - Programme 11

INTERVIEW

An interview with...

Bin Zhang

Using PCI to manage chronic total occlusions


Bin Zhang Guangdong Provincial Cardiovascular Institute Guangzhou, China
Coronary artery bypass grafting (CABG) is often the preferred revascularisation strategy for managing patients with chronic total occlusions (CTOs) because percutaneous coronary intervention (PCI) can be complicated and is associated with lower rates of revascularisation. However, PCI in this group of patients can beneficial (eg. for improved left ventricular function). Bin Zhang (Guangdong Provincial Cardiovascular Institute Guangzhou, China) reviews the use of PCI in patients with CTOs. g When a patient presents with a chronic total occlusion and is deemed eligible for revascularisation, how do you decide between PCI and CABG? When deciding between CABG and PCI, you need to consider what will provide the best long-term outcome. Patients who are being considered for PCI must have appropriate clinical indication and suitable anatomy. Appropriate clinical indications for PCI management of CTOs include persistent angina and demonstration of large reversible ischaemia on non-invasive imaging. The choice of using PCI or CABG to manage a CTO not only depends on what guidelines recommend and evidence from randomised trials, but also depends on the heart team, the interventionists skills and surgeons experience. If you are going to perform PCI in a patient with a complex lesion such as a CTO or a difficult bifurcation, then you must have the appropriate expertise. g What are the benefits of using PCI to manage CTOs? We do not have a large randomised controlled trial that compares contemporary PCI vs. optimal medical therapy for the management of CTOs. However, based on our centres experience, we do know PCI for CTO is more effective in reducing residual ischaemia and controlling symptoms of angina than optimal medical therapy alone. In my practice, most CTOs are managed with PCI rather than CABG. This is because most of my patients, as part of their culture, believe that a big cut to the chest is extremely harmful and that patients who have undergone CABG are too ill for society. The key point of using PCI to manage CTO is having a good success rate. g What are the disadvantages? PCI of CTO is technically demanding and is associated with greater radiation exposure than other PCI procedures. The procedure is also more expensive, has an increased complication rate, and has a steeper learning curve compared with PCI procedures of simpler lesions. The operators experience and choice of the various approaches to attempt the CTO intervention is critical and heavily influence the outcome of the procedure. g What key factors should you consider when choosing a device for PCI management of a CTO? You should first and foremost consider the choice of guidewires. Advances in coronary guidewire technology allow for more agile crossing of CTO lesions. Wires have been specifically designed to perform different functionsfor example, hydrophilic, enhanced force and torque wires. The choice of guidewire with its specific sensitivity is essential in determining the correct placement of the wire in the true lumen or the subintimal space. The support of the guidewire for other devices needed also plays an important role in determining the success of the CTO intervention. The emergence of new techniques and technologies is revolutionising this field. g Which access route would you usetransradial or transfemoral? Transradial PCI route is feasible for most CTO lesions. Compared with transfemoral access, the transradial route has similar rates of success and of major complications but is associated with a lower minor complication rate. If back up support from the guiding catheter is critical, the transfemoral approach using a larger guiding catheter would be advantageous. g What are your tips and techniques for performing PCI in a patient with CTO? Most of the CTO cases I have done in the last few years have been with the antegrade approach. With this approach, I prefer to use taped wires and slippery wires (such as Fielder XT and Pilot 150) because of the microchannel concept. Normally, when using antegrade approach, I use transradial access. In terms of retrograde approach, I tend to use transfemoral access with a 7F guiding catheter. The reverse controlled antegrade and retrograde tracking (CART) technique has made a significant contribution to improving the retrograde approach. Performing high-quality PCI in a patient with a CTO is an important concern and I do not think we should do too extensive dissection,with either the antegrade or retrograde approach, beyond the CTO body during PCI. g What is the post PCI management of patients with CTOs? Generally speaking, as CTO patients are usually implanted with two or more stents, they will be at risk of restenosis as well as stent thrombosis. Therefore, the duration of dual antiplatelet therapy (DAPT) needs to be sufficient to reduce the risk of stent thrombosis but at the same time, the increased risk of major bleeding with prolonged DAPT should also be considered.

AsiaPCR/SingLIVE 2014 - Programme 13

INTERVIEW

An interview with...

Kam Tim Chan

The role of imaging and functional lesion assessment


Kam Tim Chan Division of Cardiology, Queen Elizabeth Hospital, Hong Kong
Kam Tim Chan (Division of Cardiology, Queen Elizabeth Hospital, Hong Kong) reviews the tools, such as functional flow reserve (FFR), that are available for imaging and functional assessment of coronary lesions prior to or post percutaneous coronary intervention (PCI). g What do we know about fractional flow reserve (FFR)? FFR is a very useful modality to guide our management strategy, especially in patients with multivessel disease and lesions of intermediate severity. It provides an overall assessment of the collateral circulation, which can indicate that anatomical blockage in an artery functionally not actually significant. FFR has been well validated in clinical trials (eg. DEFER, FAME I, and FAME II) and international guidelines have given it a class I indication. g What are its disadvantages? There is a limitation in applying FFR to the acute stage of myocardial infarction or coronary syndromes, and also coronary artery spasm, muscular bridging and microvascular diseases. To get a good reading, FFR needs to be performed accuratelyfor example, we give adenosine to achieve maximal hyperaemia and this may cause conduction problems; bronchospasm and hypotension. Therefore, caution is required in using FFR in patients with heart block, asthma, haemodynamic instability, or severe aortic stenosis. However, it is definitely a useful modality to assess lesions of intermediate severity and lesions in which the functional significance is in doubt. g Could the use of instant wave free ratio (iFR) rather than FFR overcome some of these issues? Possibly, as iFR does not require maximal hyperaemia. At the moment, our centre is collecting data to correlate FFR readings with iFR readings, but we will definitely require more clinical data for iFR before we can apply it in our daily clinical practices. g What do we know about intravascular ultrasound (IVUS)? Compared with an angiogram, IVUS can provide a much better assessment of lesions characteristics and vessel size and is a very useful tool for optimising post PCI results. But it is still controversial whether the routine use of IVUS in conventional lesions leads to improvement in clinical outcome after PCI as there is still a lack of well validated evidence on this aspect. I think that IVUS should be used for all PCI procedures (pre and post) to the left main coronary artery as this is a very important vessel. Also, IVUS can be used to clarify the condition and help to plan the management strategy whenever ambiguity occurs in angiogram, when there is haziness after stenting, or slow flow or no reflow. g What are its disadvantages? It incurs additional cost, you need expertise and training to interpret the images, and there are reimbursement issues in many countries. Also, you may not be able to see the stent struts well owing to the lower resolution of IVUS. g What do we know about optical coherence tomography (OCT)? In contrast to IVUS, OCT has higher resolution (10-15m) than ultrasonography and you can see the intima and stent strut very well. Therefore, it is good for assessing the stent strut coverage, stent apposition, and for identifying the tiny dissection flaps or thrombus owing to its excellent resolution. Also, it can be used to assess thin cap atheroma. g What are its disadvantages? There is a lack of long-term outcome data for the modality. Also, you need to produce a bloodless field by flushing extra contrast volume. Therefore, you have to be careful of using it in patients with impaired renal function or heart failureparticularly in patients with multivessel disease where multiple imaging is needed. g What other imaging modalities do you use at your centre and why? We use CT coronary angiogram and CT perfusion studies (under clinical trial) and also regularly use MRI perfusion scanning as it is non-invasive and can provide very useful information on the anatomical and functional aspect of the lesions before subjecting these patients to an invasive test. g During imaging, what steps can you take to reduce the risks from radiation to both the patient and the operator? This is a very important issue to address in current day cardiac interventional procedures. Better planning of the procedure will reduce the total radiation exposure to patients. During each procedure, we closely monitor the total radiation dose for each patient to ensure that the exposure remains at safe levels. Also, operators need to change their projection angles regularly, particularly with complex PCI procedures such as when managing chronic total occlusions. Operators need to wear a radiation badge and have their radiation exposure closely monitored, and they also need to undergo regular body check-ups. In addition to radiation protection measures such as lead aprons and shields, using a radiation protection pad, following the radiation reduction protocol in many machines, and decreasing the use of cine angiogram are ways of reducing radiation dose to the operators.

AsiaPCR/SingLIVE 2014 - Programme 14

Scientific programme

16th-18th January, 2014 - Singapore


15th January, 2014 - Practical PCI Pre-Course

SCIENTIFIC PROGRAMME

Programme at-a-glance
8:30

9:30

10

10:30

11

11:30

12

12:30

13

13:30

14

14:30

15

15:30

16

16:30

17

17:30

18

18:30

19

19:30

20

Wednesday 15th January, 2014


Practical PCI room
Practical tips Transradial Practical aspects & transfemoral of bifurcation Lunch in PCI arterial techniques stenting access Left main stenting Acute Techniques myocardial & devices infarction beyond stent interventions implantation Imaging & functional lesion assessment Practical implications of latest trials Break

Thursday 16th January, 2014


MAIN ARENA ROOM 2 ROOM 3 ROOM 4 Interactive Case Corner Peripheral room Training Boston Scientific Training Medtronic
L &Welcome LIVE from

TOPIC 1: PCI using new technologies Focus TNT with recorded LIVE L LIVE on & Lunch Boston Scientific from Singapore wrap-up Singapore Focus on Opening Focus on complications Hong Kong & Singapore Lunch Abstracts: PCI in ACS Learning rotational atherectomy Interactive Case Corner I Lunch Symposium Abbott Vascular Symposium Maquet Cardiovascular

Interactive L TAVI with LIVE from practical session Singapore on TAVI Abstracts: Forum: outcomes with PCI DES complications Learning transseptal PTMC Interactive Case Corner II Interactive Case Corner III

Break

L LIVE

TOPIC 2: Bifurcation stenting (non left main) L LIVE HSIT from China Bifurcation from China Break

Focus on & Wrap-up

Symposium Biosensors International Symposium Medtronic & Terumo

Congenital heart interventions Forum: challenging issues with PCI Nurses, technicians & radiographers - Part I Interactive Case Corner IV Forum

Lunch

Lunch

Lunch Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system and IVUS - iLAB imaging system Innovation lab: learning with next generation devices and therapies

Carotid & renal artery stenting

Lunch

Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system and IVUS - iLAB imaging system Innovation lab: learning with next generation devices and therapies

Lunch

Friday 17th January, 2014


Break Terumo from Singapore from India

ROOM 2 ROOM 3 ROOM 4 Interactive Case Corner Peripheral room Training Boston Scientific Training Medtronic

Focus on complications India, Indonesia & Viet Nam Forum: complications MitraClip Forum: TAVI

Practical PCI tips & tricks Abstracts: structural Learning 2 stent bifurcation technique Interactive Case Corner VI My most educational case

Lunch

Symposium Biotronik Symposium OrbusNeich

L Techniques & devices: sympathetic nervoussystem for hypertension control & LIVE from Singapore
Abstracts: imaging Forum: PCI cases

Break

Break

Break

MAIN ARENA

TOPIC 3: Left Main & Multivessel Focus L LIVE L LIVE on & Lunch from Singapore from Singapore from India wrap-up
Chien Foundation

TOPIC 4: CTO

L LIVE

L TNT with LIVE

Break

Break

Break

Break

L LIVE

L LIVE

L LIVE from Singapore

Focus on & Wrap-up

Haemodynamics support

Break

Lunch

Break Break Break Break

Forum: complications Nurses, technicians & radiographers - Part II Interactive Case Corner IX OCT workshop

Break

LAA Interactive Case Corner V

Lunch

Learning transradial interventions Interactive Interactive Case Corner VII Case Corner VIII IVUS workshop FFR workshop

Break

Lunch

SFA & below the knee intervention

Break

Lunch

Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system and IVUS - iLAB imaging system Innovation lab: learning with next generation devices and therapies

Lunch

Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system and IVUS - iLAB imaging system Innovation lab: learning with next generation devices and therapies

Lunch

Saturday 18th January, 2014


Thailand Invasive imaging and physiology (IVUS/OCT/ FFR)- Part I Interactive Case Corner X from Singapore Break Break

MAIN ARENA ROOM 2 Interactive Case Corner Training Boston Scientific Training Medtronic

Awards

L LIVE

L LIVE from Thailand

Invasive imaging and physiology (IVUS/OCT/ FFR) - Part II

Interactive Case Corner XI

Break

Interactive Case Corner XII

Interactive workshop: rotablator atherectomy system, VESSIX renal denervation system and IVUS - iLAB imaging system Innovation lab: learning with next generation devices and therapies

8:30

9:30

10

10:30

11

11:30

Closing

LIVE L from

TOPIC 5: Transradial Lunch with Course Directors


NEW!

12

12:30

13

13:30

14

14:30

15

15:30

16

16:30

17

17:30

18

18:30

19

19:30

20

Plenary session 16

L With LIVE

Interactive Case Corner

Educative sessions

Industry-supported sessions

Training village AsiaPCR/SingLIVE 2014 - Programme 16

SCIENTIFIC PROGRAMME

Programme
Wednesday 15th January, 2014
PRACTICAL PCI ROOM ___ 09:30-17:50 ____________________________________ Attend this PCI Practical Pre-Course if you want: g To learn how to do basic PCI g To learn the different techniques to approach the cases 09:30-10:30 ____________________________ Plenary session Practical tips in PCI techniques Chairpersons: E. Eeckhout, T.H. Koh Panellists: A. Ong, D. Tresukosol, W. Wijns, A. Wong g 10 mn Introduction - T.H. Koh g 10 mn Choice and manipulation of diagnostic and guiding catheters - A. Ong g 10 mn Choice and manipulation of guide wires - D. Tresukosol g 10 mn Antiplatelet therapy - W. Wijns g 10 mn Management of uncommon situations - A. Wong g 10 mn Discussion & audience interaction 10:35-11:20 ____________________________ Plenary session Transradial and transfemoral arterial access Chairpersons: B. Chevalier, J. Tan Panellists: L. Bilodeau, T. Slagboom g 5 mn Introduction - B. Chevalier g 10 mn Transradial interventions: how to deal with hostile anatomy - T. Slagboom g 10 mn Management of vascular complications - J. Tan g 10 mn Transradial access (saphenous vein graft, Lima, Rima, sheathless) - L. Bilodeau g 10 mn Discussion & audience interaction 11:25-12:20 ____________________________ Plenary session Practical aspects of bifurcation stenting Chairpersons: M.C. Morice, R. Zambahari Panellists: P. Chandra, N. Foin, B. Garcia Del Blanco, R.I. Low, W.A. Wan Azman g 10 mn Technical considerations in bifurcation stenting Benchtop lessons - N. Foin g 10 mn True bifurcation with only one stent - P. Chandra g 10 mn Culotte bifurcation stenting - B. Garcia Del Blanco g 10 mn T and TAP Stenting - M.C. Morice g 10 mn Crush/mini crush - W.A. Wan Azman g 5 mn Discussion & audience interaction 13:00-13:45 ____________________________ Plenary session Left main stenting Chairpersons: J. Fajadet, T. Santoso Panellists: C. Briguori, W. Kehasukcharoen g 5 mn Introduction - J. Fajadet g 10 mn Imaging assisted left main stenting role of IVUS W. Kehasukcharoen g 10 mn Ostial left main stenting and provisional T stenting T. Santoso g 10 mn Distal bifurcation stenting (including simultaneous kissing stent) - J. Fajadet g 10 mn Discussion & audience interaction 13:50-14:45 ____________________________ Plenary session Acute myocardial infarction interventions Chairpersons: P. Chandra, A. Wong Panellists: R. Bhindi, C. Briguori, M. DAmico, J.F. Iglesias, M. Noc g 5 mn Introduction - A. Wong g 10 mn Use of new antiplatelet drugs and IIB-IIIA inhibitors R. Bhindi g 10 mn How to perform thrombectomy and distal protection J.F. Iglesias g 10 mn Managing cardiogenic shock in acute myocardial infarction - M. Noc g 10 mn Complications management - M. Damico g 10 mn Discussion & audience interaction 14:50-15:40 ____________________________Plenary session Techniques and devices beyond coronary stent implantation Chairpersons: C.K. Naber, D. Tresukosol Panellists: C. Briguori, I.H. Chae, N. Inoue, E. Merkulov, R. Zambahari g 10 mn Drug-eluting balloons and cutting balloons I.H. Chae g 10 mn ABC of rotablation - R. Zambahari g 10 mn When the balloon does not cross the lesion E. Merkulov g 10 mn When you cannot deliver the stent - N. Inoue g 10 mn Discussion & audience interaction 15:55-16:50 ____________________________ Plenary session Imaging and functional lesion assessment Chairpersons: G. Guagliumi, S.T. Lim Panellists: K.T. Chan, A. Low g 5 mn Introduction - S.T. Lim g 10 mn ABC of FFR - A. Low g 10 mn 10 rules on radiation protection - S.T. Lim g 10 mn IVUS tips and tricks in interpretation - K.T. Chan g 10 mn ABC of OCT - G. Guagliumi g 10 mn Discussion & audience interaction 16:55-17:50 ____________________________ Plenary session Practical implications of latest trials Chairpersons: M. Munawar, W. Wijns Panellists: S. Mishra, R.I. Low g 3 mn Introduction - M. Munawar g 10 mn Acute coronary syndrome - R.I. Low g 10 mn Stent trials g 10 mn Multivessel and left main PCIs - M. Munawar g 10 mn Focus updates on new technologies drug-eluting balloons, bioresorbable scaffolds - S. Mishra g 7 mn Discussion & audience interaction g 5 mn Wrap-up of the day - W. Wijns End of the day

AsiaPCR/SingLIVE 2014 - Programme 17

SCIENTIFIC PROGRAMME

Programme
Thursday 16th January, 2014
MAIN ARENA ___ 09:00-10:15 ____________________________________ ___ 10:35-12:00 ____________________________________

Topic: PCI using new technologies


Attend these sessions if you want: g To learn about the new drug delivery stents g To learn how they can potentially reduce dual antiplatelet therapy duration g To understand the value of intraconary imaging in this particular setting 10:35-11:35 _________________________ LIVE demonstration LIVE demonstration from the National Heart Centre Singapore Chairpersons: E. Eeckhout, T.H. Koh Panellists: E. Grube, H.C. Gwon, U. Kaul, M. Lee, S. Mishra, P.W. Serruys, D. Tresukosol, T.N. Vo , W.A. Wan Azman Operators: J.M. Fam, S.T. Lim IVUS moderator: J. Honye With continuous LIVE demonstration from the National Heart Centre Singapore 11:35-11:55 ________________________________Focus on Focus on dual antiplatelet therapy duration Chairpersons: E. Eeckhout, T.H. Koh Panellists: E. Grube, H.C. Gwon, U. Kaul, M. Lee, S. Mishra, P.W. Serruys, D. Tresukosol, T.N. Vo , W.A. Wan Azman g 15 mn Shortening dual antiplatelet therapy duration H.C. Gwon g 5 mn Global leaders trial presentation - P.W. Serruys 11:55-12:00 ____________________________ Plenary session Wrap-up Chairpersons: E. Eeckhout, T.H. Koh Panellists: E. Grube, H.C. Gwon, U. Kaul, M. Lee, S. Mishra, P.W. Serruys, D. Tresukosol, T.N. Vo , W.A. Wan Azmann g 5 mn Wrap-up by Damras Tresukosol End of the topic

Topic: PCI using new technologies


Attend these sessions if you want: g To learn about the advanced applications on bioresorbable scaffolds g To understand the value of intracoronary imaging in this particular setting 09:00-10:00 _________________________ LIVE demonstration Welcome and LIVE demonstration from the National Heart Centre Singapore Chairpersons: E. Eeckhout, T.H. Koh Panellists: J.J. Cheng, J.B. Ge, M.C. Morice, C.K. Naber, S. Saito, P.W. Serruys, A. Seth, W. Wijns Operators: J. Fajadet, A. Wong IVUS Moderator: J. Honye With continuous LIVE demonstration from the National Heart Centre Singapore 10:00-10:15 ________________________________Focus on Focus on bioresorbable scaffolds Chairpersons: E. Eeckhout, T.H. Koh Panellists: J.J. Cheng, J.B. Ge, M.C. Morice, C.K. Naber, S. Saito, P.W. Serruys, A. Seth, W. Wijns g 15 mn Focus on bioresorbable scaffolds: the top 10 unanswered questions - P.W. Serruys End of the topic

Opening session
___ 10:15-10:30 ___________________________ Plenary session Welcome address Chairpersons: E. Eeckhout, T.H. Koh Panellists: J.B. Ge, M.C. Morice, C.K. Naber, S. Saito, P.W. Serruys, A. Seth, W. Wijns g 5 mn Opening ceremony - T.H. Koh g 5 mn Presentation of the Course and todays programme E. Eeckhout g 5 mn PCR Family - W. Wijns

AsiaPCR/SingLIVE 2014 - Programme 18

SCIENTIFIC PROGRAMME

Thursday 16th January, 2014 - Main Arena


___ 12:35-13:55 ______________________ Tools & Techniques (TNT) Advancing cardiology together with innovative technologies and meaning clinical research With an unrestricted educational grant from Boston Scientific Chairpersons: J. Fajadet, T.H. Koh Panellists: D.C.Y. Cheung, C.T. Chin, L. Kalidoss, A. Menon, M.C. Morice, A. Ong, F. Posas, T. Selvan Attend this session if you want: g To learn how polymers and stent materials impact healing g To demonstrate the Vessix multi-point system features and its anatomical and clinical use g To introduce Lotus: safety and performances
g 2 mn Introduction and objectives - T.H. Koh g 10 mn Clinical evidences in catheter-based renal sympathetic g 30 mn g 5 mn g 15 mn g 5 mn g 10 mn g 3 mn

___ 16:15-17:55 ____________________________________

Topic: Bifurcation stenting (non left main)


Attend these sessions if you want: g To understand indication and techniques in the treatment of ostial side branch lesion 16:15-17:15 _________________________ LIVE demonstration LIVE demonstration from Xijing Hospital, Xi-an, China Chairpersons: J. Fajadet, S.T. Lim Panellists: J. Berland, S.L. Chen, B. Chevalier, J.B. Ge, M.C. Morice, M. Ochiai, A. Ong, A. Seth, H. Suryapranata Operator: W.Y. Guo With continuous LIVE demonstration from Xijing Hospital, Xi-an, China 17:15-17:50 _______________________________ Focus on Focus on bifurcation Chairpersons: J. Fajadet, S.T. Lim Panellists: J. Berland, S.L. Chen, B. Chevalier, J.B. Ge, M.C. Morice, M. Ochiai, A. Ong, A. Seth, H. Suryapranata g 10 mn Bifurcation stenting techniques using bioresorbable scaffolds - A. Seth g 10 mn When to consider using dedicated bifurcation stents B. Chevalier g 15 mn My 10 keypoints about bifurcation stenting M.C. Morice 17:50-17:55 ____________________________Plenary session Wrap up Chairpersons: J. Fajadet, S.T. Lim Panellists: J. Berland, S.L. Chen, B. Chevalier, J.B. Ge, M.C. Morice, M. Ochiai, A. Ong, A. Seth, H. Suryapranata g 5 mn Wrap-up by Jean Fajadet End of the topic ___ 18:00-19:20 ______________________________ Symposium New concepts for improved patient outcomes With an unrestricted educational grant from Biosensors International Chairpersons: T.H. Koh, K.G. Oldroyd Panellists: B. Garcia Del Blanco, F.Y. Kuo, J. Tan Attend this session if you want: g To learn about the new concepts in treating patients for better clinical outcomes g To understand clinical benefits to use biodegradable polymer DES in acute myocardial infarction patients g To gain insights on dual antiplatelet therapy early discontinuation
g 5 mn Introduction and objectives - T.H. Koh g 15 mn Changing practice: is it safe to use biodegradable

denervation: building the data - F. Mahfoud Recorded LIVE demonstration: vessix - C.T. Chin Discussion & audience interaction Unique abluminal bioabsorbable polymer and a unique customised architecture - H.C. Tan Discussion & audience interaction TAVR LOTUS Valve - E. Grube Take-home message - J. Fajadet

___ 14:00-16:00 ____________________________________

Topic: Bifurcation stenting (non left main)


Attend these sessions if you want: g To learn the different 2 stent techniques for complex bifurcation g To learn about the value of functional and morphological assessment during intervention in this setting 14:00-15:00 _________________________ LIVE demonstration LIVE demonstration from Xijing Hospital, Xi-an, China Chairpersons: R. Ng, W. Wijns Panellists: I.H. Chae, M.S. Kalarickal, P.W. Serruys, J. Tan, E. Tsuchikane, C.J. Wu, F. Yoshimachi, R. Zambahari Operator: W.Y. Guo With continuous LIVE demonstration from Xijing Hospital, Xi-an, China 15:00-16:00 ____________________ How should I treat? session How should I treat bifurcation? Chairpersons: R. Ng, W. Wijns Panellists: I.H. Chae, M.S. Kalarickal, P.W. Serruys, J. Tan, E. Tsuchikane, C.J. Wu, F. Yoshimachi, R. Zambahari g 5 mn Case presentation - S.L. Chen g 5 mn How would I treat? - H.H. Ho g 5 mn How would I treat? - A. Seth g 10 mn How did I treat? - S.L. Chen g 5 mn Discussion and audience interaction g 5 mn Case presentation - D. Tresukosol g 5 mn How would I treat? - W. Wijns g 5 mn How would I treat? - T. Santoso g 10 mn How did I treat? - D. Tresukosol g 5 mn Discussion and audience interaction End of the topic

polymer DES in acute myocardial infarction? - F.Y. Kuo


g 15 mn Long-term outcomes with BioLimus from BEACON II

Asia Population - T.H. Koh


g 15 mn Raising the standard in treating bifurcation lesions

B. Garcia Del Blanco


g 15 mn Patients with high bleeding risk: which stent, which

dual antiplatelet therapy regimen - K.G. Oldroyd


g 10 mn Discussion & audience interaction g 5 mn Take-home message - K.G. Oldroyd

AsiaPCR/SingLIVE 2014 - Programme 19

SCIENTIFIC PROGRAMME

Programme
Thursday 16th January, 2014
ROOM 2 ___ 10:30-12:00 ____________________________ Plenary session Focus on stent related complications: Hong Kong and Singapore With the collaboration of the Hong Kong College of Cardiology and the National Heart Centre Singapore Chairpersons: K.T. Chan, P. Wong Panellists: W.H.N.S.C. Chan, J. Berland, G.H. Choo, M. Yamin, C.K.Y. Wong Attend this session if you want: g To learn how to manage coronary complications
g 12 mn In-stent restenosis coronary chronic total occlusion:

___ 14:00-16:00 ___________________________ Plenary session

Sessions on TAVI
Attend these sessions if you want: g To understand what TAVI can offer to your patients, with CoreValve & Sapien device g To raise knowledge on how to successfully perfom TAVI procedure with CoreValve & Sapien device 14:00-15:00 _________________________ LIVE demonstration LIVE demonstration from the National Heart Centre Singapore Chairpersons: R.M. Ali, M. Thomas Panellists: S. Cook, E. Grube, K. Hayashida, F. Posas, S. Redwood, Y.K.K. Sin, D. Tchtch Operators: P. Chiam, K.W. Ho 3D TEE moderator: S.H. Ewe Surgical expert: J.L. Soon With continuous LIVE demonstration from the National Heart Centre Singapore 15:00-16:00 ___________________________ Plenary session Case-based interactive discussion on TAVI Facilitators: R.M. Ali, S. Redwood Panellists: S. Cook, E. Grube, K. Hayashida, F. Posas, Y.K.K. Sin, D. Tchtch, M. Thomas With recorded LIVE demonstration ___ 16:15-17:55 ____________________________ Plenary session Congenital heart interventions Chairpersons: E. Eeckhout, J.L. Tan Panellists: M. Alwi, S. Chandra, P.C. Mondal, M.H. Pham, S. Radhakrishnan, J. Yip Attend this session if you want: g To learn about contemporary treatment of common congenital heart disease
g 5 mn Introduction - J.L. Tan g 15 mn Practical approach to closing large and complex atrial

g 3 g 12 g 3 g 12 g 3 g 12

mn mn mn mn mn mn

g 3 mn g 12 mn g 3 mn g 12 mn g 3 mn

same subintimal tracking and re-entry (STAR) or different beast - L. Ho Discussion & audience interaction Case presentation - H.K. Woon Discussion & audience interaction The only 1,5% - E. Wong Discussion & audience interaction Left main stent compression - an oops! moment J.H. Jafary Discussion & audience interaction A case of unprotected left main intervention complicating acute stent thrombosis - G. Cheung Discussion & audience interaction What matters in thrombosis? - R.C.H. Lee Discussion & audience interaction

___ 12:35-13:55 ______________________________ Symposium Polymer DES safety and BVS case sharing With an unrestricted educational grant from Abbott Vascular Chairperson: R. Ng Panellists: S.T. Lim, A. Low, D.N. Muda, J. Tan, R.J. Van Geuns Attend this session if you want: g To understand biodegradable polymer does not contribute extra benefit in DES g To share BVS Performance in acute myocardial infarction and bifurcation
g 5 mn Introduction and objectives - S.T Lim g 20 mn Biodegradable polymer offers no extra benefit in DES g 20 mn g 20 mn g 10 mn g 5 mn

septal defects - S. Radhakrishnan


g 3 mn Discussion & audience interaction g 8 mn Successful percutaneous device closure for giant atrial

J. Tan BVS case based discussion in acute myocardial infarction - A. Low BVS case based discussion in bifurcation - RJ. Van Geuns Discussion & audience interaction Take-home message - R. Ng

g 4 mn g 15 mn g 3 g 8 g 4 g 15 mn mn mn mn

g 3 mn g 8 mn

g 4 mn g 5 mn

septal defect with massive pericardial effusion and pulmonary hypertension in an elderly patient T. Sakamoto Discussion & audience interaction CoA stenting: what is known and what is new M.H. Pham Discussion & audience interaction Plug the arteriovenous malformation (AVM) - V. Kumar Discussion & audience interaction Practical tips for successful pulmonary valvuloplasty and stenting arteries - M. Alwi Discussion & audience interaction A case of chronic thromboembolic pulmonary hypertension disengaged from oxygen therapy after balloon pulmonary angioplasty - R. Fukuoka Discussion & audience interaction Consensus - E. Eeckhout

AsiaPCR/SingLIVE 2014 - Programme 20

SCIENTIFIC PROGRAMME

Thursday 16th January, 2014 - Room 2


___ 18:00-19:20 ______________________________ Symposium Shared symposium on catheter-based renal sympathetic denervation With an unrestricted educational grant from Medtronic and Terumo Part I: Leading the way in the renal denervation: the Symplicity innovation programme Chairperson: F. Mahfoud Panellists: S.T. Lim, J.K.B. Tan, T.W. Lim Attend this session if you want: g To learn about clinical data from Symplicity HTN-1, HTN-2, and Global Symplicity Registry in Asia Pacific g To learn about the First in Man experience with g Symplicity Spyral and the Symplicity Design Story g To learn about Symplicity HTN-3 and HTN-4 trial design and interpreting ABPM vs OBPM results
g 3 mn Introduction & objectives - F. Mahfoud g 10 mn How far have we come? Symplicity HTN-1,-2, Global

ROOM 3 ___ 10:30-12:00 ____________________________ Abstract session Abstracts: PCI in Acute coronary syndrome Session comprising selected AsiaPCR/SingLIVE 2014 abstracts submissions Chairpersons: Y.T. Lim, O. Varenne Panellists: T. Slagboom, C.H. Tan, P. Tedjokusumo
g 8 mn Comparable low rates of major adverse cardiovascular

g 4 mn g 8 mn

Symplicity registry - S.T. Lim


g 10 mn Where are we now? Spryral, design story - J.K.B. Tan g 10 mn How far can we go? ABPM vs OBP, Symplicity HTN-3,-4,

g 5 mn g 8 mn

HF - T.W. Lim
g 5 mn Discussion & audience interaction g 2 mn Take-home message - F. Mahfoud g 5 mn g 8 mn

Part II: Towards better patients care: optimising renal sympathetic denervation Chairpersons: F. Mahfoud, T. Santoso Panellists: T. Benjanuwattra, H.H. Ho Attend this session if you want: g To learn about current renal sympathetic denervation and future potential g To discuss about less invasive renal nerve ablation procedure from radial artery; its benefits and challenges g To learn about experience of Iberis Renal Sympathetic Denervation Systems
g 5 mn Introduction and objectives - T. Santoso g 10 mn Renal sympathetic denervation: current and future

g 5 mn g 8 mn

g 5 mn g 8 mn

g 5 mn g 8 mn

F. Mahfoud
g 10 mn Renal denervation and its potential benefit and

challenge of transracial approach - H.H. Ho g 10 mn Case presentation - T. Benjanuwattra g 5 mn Take-home message - F. Mahfoud

g 5 mn

events in patients with ST-elelvation and non ST-elevation acute coronary syndromes treated with biolimus eluting stents in the 12-month follow-up of the all-comers e-BioMatrix registry - K.G. Oldroyd Discussion & audience interaction Efficacy of Lacrosse NSE balloon using the LeopardCrawl technique on severely calcified lesions K. Ashida Discussion & audience interaction Procedural implications of persistent right innominate artery tortuosity (tapan sign) during right transradial or trans ulnar coronary intervention: a prospective case controlled multicentre study - T. Ghose Discussion & audience interaction Impact of endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug eluting stent - S.H. Kim Discussion & audience interaction 5 years clinical follow up results of endothelial cell capturing stents in acute coronary syndrome in Indian patients - T. Ghose Discussion & audience interaction Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients with acute coronary syndrome - T.H. Kim Discussion & audience interaction TIMI myocardial perfusion grade (TMPG) and myocardial viability (MV) assessment using dobutamine stress echocardiogram in patients post acute coronary syndromes - J.R. Ismail Discussion & audience interaction

AsiaPCR/SingLIVE 2014 - Programme 21

SCIENTIFIC PROGRAMME

Programme
Thursday 16th January, 2014 - Room 3
___ 12:35-13:55 ______________________________ Symposium Tailoring haemodynamic support to the specific needs of the unstable patient undergoing PCI With an unrestricted educational grant from Maquet Cardiovascular Chairpersons: S. Redwood, A. Wong Panellists: P. Chandra, P.J.L. Ong, M. Thomas, S. Rathnavel Attend this session if you want: g To discuss the haemodynamics of mechanical circulatory support in the unstable patient undergoing PCI g To understand the indications for percutaneous extracorporeal membrane oxygenation (ECMO) vs. percutaneous ventricular assist or intra-aortic balloon pump therapy g To discuss real world experience and outcomes in treating complex PCI procedures
g 5 mn Introduction and objectives - A. Wong g 10 mn Case presentation: percutaneous extra-corporeal

15:05-16:00 ____________________________________ Forum Forum: PCI Complications Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Chairpersons: F. Mahfoud, S.C. Ng Panellists: T. Benjanuwattra, C.Y. Chou, B. Zhang g 8 mn A case of successful bailing out from severe longitudinal deformation due to an inner catheter after postdilation with a large-caliber balloon - Y. Seiji g 4 mn Discussion & au dience interaction g 8 mn Diffuse calcified lesion: a sticky encounter - S. Khan g 4 mn Discussion & audience interaction g 8 mn Catheter-induced dissection at ostium of right coronary artery with abnormal origin - N.Q. Nguyen g 4 mn Discussion & audience interaction g 8 mn Why knot? - V. Mironov g 4 mn Discussion & audience interaction ___ 16:15-17:45 _________________________________ Forum Forum: challenging issues in PCI Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Chairpersons: P.W. Serruys, P. Yan Panellists: M. Chan, A.A. Lukito, Q.T. Nguyen, T.P. Tsao g 8 mn Acute anterior STEMI immediately post CABG: how to manage? - K. Fouad g 4 mn Discussion & audience interaction g 9 mn STEMI in a young lady with deficient protein S H. Shaalan g 4 mn Discussion & audience interaction g 9 mn Acute ST-elevation myocardial infarction triggered by drinking bhang (cannabis) - D. Natarajan g 4 mn Discussion & audience interaction g 9 mn When the itching hurts - M. Cardenas Manilla g 4 mn Discussion & audience interaction g 9 mn An unusual case of new coronary lesion of left main and just proxysmal left anterior descending artery after Bentall operation successfully treated with percutaneous - H. Tsuneoka g 4 mn Discussion & audience interaction g 9 mn Stent graft failure eight years post insertion in a left internal mammary artery (LIMA) graft to close a missed side branch - N. Okasha g 4 mn Discussion & audience interaction g 9 mn PCI in dextrocardia situs inversus and severe hypothyroidism - D. Natarajan g 4 mn Discussion & audience interaction

g 10 g 10 g 5 g 10 g 10 g 10 g 5 g 5

mn mn mn mn mn mn mn mn

membrane oxygenation vs. percutaneous ventricular assist or intra-aortic balloon pump therapy: which device and when? - P. Chandra How would I treat? Expert opinion - P.J.L. Ong How would I treat? Expert opinion - M. Thomas How did I treat? - P. Chandra Case presentation: IABP SHOCK II Trial: what does this mean for your clinical practice? - S. Rathnavel How would I treat? Expert opinion - P.J.L. Ong How would I treat? Expert opinion - M. Thomas How did I treat? - S. Rathnavel Take-home message - S. Redwood

___ 14:00-15:00 ____________________________ Abstract session Abstracts: outcomes with drug eluting stent Session comprising selected AsiaPCR/SingLIVE 2014 abstracts submissions Chairpersons: S. Hardt, K.H. Sim Panellists: B.B. Darmadjati, A. Rahman, R.J. Van Geuns, Y.H. Oktaviono g 8 mn Four year clinical outcomes and predictors of coronary revascularisation among patients treated with newer-generation drug-eluting stents - M. Taniwaki g 4 mn Discussion & audience interaction g 8 mn Very long time follow-up after percutaneous closure of patent foramen ovale - E. Eeckhout g 4 mn Discussion & audience interaction g 8 mn Very long-term safety and efficacy outcomes of all comers BEACON II registry: five year follow-up and final report of the study - T.H. Koh g 4 mn Discussion & audience interaction g 8 mn Does the existence of primer coating on biolimuseluting stents with abluminal biodegradable polymer influence clinical outcomes? Insights from the large all-comers eBioMatrix registry - I. Menown g 4 mn Discussion & audience interaction g 8 mn Decreasing importance of distance from home to the nearest invasive centre for performing diagnostic coronary angiography among patients with acute coronary syndromes: a national study - S. Galatius g 4 mn Discussion & audience interaction

AsiaPCR/SingLIVE 2014 - Programme 22

SCIENTIFIC PROGRAMME

Thursday 16th January, 2014


ROOM 4 ___ 14:00-14:40 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: J. Fajadet, G. Sengottuvelu g Very late stent thrombosis (VLST) occurring five years after deployment of second generation drug-eluting stent treated by bioresorbable scaffolds during transradial direct primary angioplasty without prior knowledge of right coronary artery anatomy - T. Ghose g A case of retrograde PCI for left circumflex coronary chronic total occlusion from ipsilateral channel: how to get skill of retrograde approach - M. Yoshida g Nightmares in Cathlab Title: what did happen at the end of PCI and stenting? - S.M. Hossain g Simultaneous coronary and valvular intervention - M. Srinivas ___ 14:45-16:00 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: J.B. Ge, M.C. Morice g Coronary AV fistula closure during primary PCI for inferior STEMI - N. Okasha g Retrograde chronic coronary total occlusion intervention via ipsilateral collaterals - S. Victor g Where we went wrong: mortality - R. Chawla g Coronary aneurysm after DES implantation in a psoriatic patient - L.P. Suciadi g Preventive PCI in bifurcated left main disease in the setting of primary PCI where the culprit vessel is the right coronary artery - H. Rahman g Microcatheter support good way to deliver stents G. Sengottuvelu ___ 16:15-17:30 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: N. Chouhan, W.A. Wan Azman, W. Wijns g OCT guided PCI with single stenting of left main coronary artery to left circumflex to obtuse marginal (OM) branch K. Sridhar g Left main stenosis and infarct-related left anterior descending artery: single-stage or sequent PCI? - E. Merkulov g Use of bioresorbable scaffolds during transradial primary angioplasty - T. Ghose g Successful angioplasty of right coronary artery coronary chronic total occlusion and left main bifurcation lesions C.C. Chang g What happened to this young lady with acute myocardial infarction? - J.M. Fam

___ 10:30-12:00 _____________________________________ Learning rotational atherectomy Facilitators: T. Cuisset, J. Tan, D. Tchtch Resource experts: M.S. Kalarickal, R.I. Low Media driver: D. Yong Attend this session if you want: g To review the basic principles, patient and lesion selection for rotational atherectomy g To understand how to safely and successfully perform a rotational atherectomy g To find out how to solve the most frequent issues ___ 14:00-16:00 _____________________________________ Learning transseptal and percutaneous transseptal mitral commissurotomy Facilitators: S. Khan, K.K. Yeo Resource expert: M.H. Pham Media driver: K.L. Leow Attend this session if you want: g To learn the techniques of transseptal puncture and percutaneous transseptal mitral commissurotomy g To review the indications and evidence of percutaneous transseptal mitral commissurotomy g To understand and manage complications ___ 16:15-17:50 _____________________________________ Nurses, technicians and radiographers - Part I Assisting for FFR measurements in the cathlab Facilitators: S. Buendia, C.T. Chin, V. Kwok Resource expert: K.T. Chan Attend this session if you want: g To understand the key roles of cathlab professionals and team work in performing FFR measurements with a pressure wire

INTERACTIVE CASE CORNER ___ 10:30-12:00 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: R.K. Abhaichand, B. Chevalier g Same costume, different character - M. Cardenas Manilla g Price of missing ostium - R. Chawla g The curious case of the intermittently open and close vessel C.T. Chin g ACS and severily calcified left main disease: how should I treat? - V. Mironov g Severely calcified left main bifurcated lesion treated with rotational atherectomy and culottes stenting - H. Nishina g PCI in single coronary artery: a challenging case - S. Khanal g Complicated primary PCI: what is wrong with our approach? L.H. Dinh

AsiaPCR/SingLIVE 2014 - Programme 23

SCIENTIFIC PROGRAMME

Programme
Thursday 16th January, 2014

PERIPHERAL PROGRAMME
3rd FLOOR ___ 14:00-16:00 ____________________________ Plenary session Carotid and renal artery stenting and Takayasu arteritis intervention Chairpersons: S.W. Rha, M. Taneja Panellists: C.I. Cheng, B. Chua g 2 mn Introduction and objectives - S.W. Rha g 10 mn Catheters, guidewires and embolic protection devices for carotid angioplasty: what is new in 2014? - S.W. Rha g 10 mn 2014 update on carotid artery stenting versus carotid endarterectomy: does carotid artery disease still have a future? - N. Khanna g 10 mn My top tips and tricks for carotid artery stenting S.W. Rha g 12 mn A case of carotid artery stenting that I regret doing M. Taneja g 10 mn Debate: after CORAL, ASTRAL and STAR trials, is there still a role for renal artery stenting? definitely - S.T. Lim g 10 mn Debate: after CORAL, ASTRAL and STAR trials, is there still a role for renal artery stenting? no way - C.M. Chan g 8 mn An educational case of renal artery stenting - K. Sridhar g 4 mn Discussion & audience interaction g 10 mn My top dos and donts for renal artery stenting S.W. Rha g 12 mn Takayasus arteritis: endovascular treatment tips and tricks - N. Khanna g 8 mn A memorable case of Takayasu arteritis intervention K. Sridhar g 14 mn Discussion & audience interaction ___ 16:15-17:30 _________________________________ Forum Peripheral case forum Chairpersons: N. Khanna, K.K. Yeo Panellists: B. Chua, F.Y. Kuo, F. Posas, S.W. Rha, J. Tan, D. Tresukosol g 3 mn Introduction and objectives - N. Khanna g 8 mn Successful treatment of acute femoral artery occlusion by percutaneous Fogarty balloon catheter embolectomy - Y. Takahashi g 4 mn Discussion & audience interaction g 8 mn A case of endovascular fenestration for aortic dissection Stanford type B with acute malperfusion M. Sato g 4 mn Discussion & audience interaction g 8 mn Interventional closure of pseudo aneurysm developed following Percutaneous transluminal angioplasty with stenting of abdominal aorta - A.K. Mahapatro g 4 mn Discussion & audience interaction g 8 mn Useful three-dimensional information provided by angioscopy during lower limb intervention: a case report - N. Takafumi g 4 mn Discussion & audience interaction g 8 mn In stent occlusive lesion treated by eccentric method, direct superficial femoral artery stent puncture T. Haraguchi g 4 mn Discussion & audience interaction

TRAINING WORKSHOPS
BOSTON SCIENTIFIC TRAINING ROOM ___ 09:00-12:00 _____________________________________ ___ 13:00-17:00 _____________________________________ Interactive workshop: rotablator atherectomy system, Vessix renal denervation system and IVUS - iLAB imaging system With an unrestricted educational grant from Boston Scientific Attend this session if you want: g To have hands-on training on the use of Rotablator in wetheart model g To have hands-on training on the use of Vessix Renal Denervation System g To have hands-on training on the use of iLAB imaging System
g Rotablator atherectomy system: pre-treating calcified lesions

MEDTRONIC TRAINING ROOM ___ 08:30-12:00 _____________________________________ ___ 12:30-17:30 _____________________________________ Innovation lab: learning with next generation devices and therapies With an unrestricted educational grant from Medtronic Attend this session if you want: g To learn with next generation devices and therapies
g Simulator training on Medtronic next generation Spyral catheter

for resistant hypertension treatment


g A look into Medtronic next generation stent development

and coronary product pipeline presentation

with rotational atherectomy can be one of the best way to enhance proper stent placement. The Rotablator System provides an excellent option for treating calcified lesions, with a complete family of products g Vessix renal denervation system: designed to reduce blood pressure in resistant hypertensive patients while offering the familiarity of an over-the-wire balloon catheter, the precision of bipolar energy delivery in the shortest treatment time g IVUS -iLAB Imaging System: IVUS (Intravascular Ultrasound) is a catheter-based system that provides a dramatic improvement in the diagnosis and management of coronary artery disease
AsiaPCR/SingLIVE 2014 - Programme 24

SCIENTIFIC PROGRAMME

Friday 17th January, 2014


MAIN ARENA ___ 08:30-12:00 ____________________________________ 11:55-12:00 ____________________________Plenary session Wrap-up Chairpersons: M.C. Morice, P. Wong Panellists: M. Bedossa, P. Chandra, J.J. Cheng, C.Y. Chou, J.S. Hiremath, R.I. Low, M. Munawar, Q.T. Nguyen, S.J. Park g 5 mn Wrap-up by Jun-Jack Cheng End of the topic ___ 12:35-13:55 ______________________________ Symposium Toward a better patient care: beyond the limitation of transradial intervention With an unrestricted educational grant from Terumo Corporation Chairpersons: M.C. Morice, S. Saito Panellists: T. Akasaka, J. Fajadet, Y. Hamazaki, D. Firman, S.Y. Lee, F. Malik, P.J.L. Ong, T. Yamashita, F. Yoshimachi Operators: R.M. Ali, K.W. Ho OFDI commentator: T. Akasaka Attend this session if you want: g To overcome the challenges of transradial intervention for complex case using imaging technique g To discuss the remaining issues of transradial approach and if slender transradial intervention concept can improve them g To learn about less invasive renal nerve ablation procedure from radial artery, its benefit and challenge
g 2 mn Introduction and objectives - S. Saito g 30 mn LIVE demonstration from the National Heart Centre

Topic: Left Main & Multivessel


Attend these sessions if you want: g To understand patient selection and treatment strategy g To learn about the value of imaging g To learn about the value of functional and morphological assessment during intervention in this setting 08:30-09:25 _________________________ LIVE demonstration LIVE demonstration from the National Heart Centre Singapore Chairpersons: P.W. Serruys, H.C. Tan Panellists: R.M. Ali, R. Bhindi, W. Buddhari, K.T. Chan, J.M. De La Torre Hernandez, F. Malik, M.H. Pham, T. Santoso, M. Thomas, R.J. Van Geuns Operators: C.T. Chin, E. Grube React@PCR moderator: J.F. Iglesias, J. Loh With continuous LIVE demonstration from the National Heart Centre Singapore 09:25-09:35 ___________________________ Plenary session Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI Chairpersons: P.W. Serruys, H.C. Tan Panellists: R.M. Ali, R. Bhindi, W. Buddhari, K.T. Chan, J.M. De La Torre Hernandez, F. Malik, M.H. Pham, T. Santoso, M. Thomas, R.J. Van Geuns
g 10 mn Award given to Marie-Claude Morice - R. Ng

Singapore - R.M. Ali


g 5 mn Discussion & audience interaction g 10 mn The evolution of less invasive PCI - F. Yoshimachi g 10 mn Doing our best to treat AMI: doing it transradially

09:35-10:30 _________________________ LIVE demonstration LIVE demonstration from the National Heart Centre Singapore Chairpersons: P.W. Serruys, H.C. Tan Panellists: R.M. Ali, R. Bhindi, W. Buddhari, K.T. Chan, J.M. De La Torre Hernandez, F. Malik, M.H. Pham, T. Santoso, M. Thomas, R.J. Van Geuns Operators: S. Saito, J. Tan React@PCR moderator: J.F. Iglesias, J. Loh With continuous LIVE demonstration from the National Heart Centre Singapore 10:45-11:40 _________________________ LIVE demonstration LIVE demonstration from Continental Hospitals, Hyderabad, India Chairpersons: M.C. Morice, P. Wong Panellists: M. Bedossa, P. Chandra, J.J. Cheng, C.Y. Chou, J.S. Hiremath, R.I. Low, M. Munawar, Q.T. Nguyen, S.J. Park Operators: S.K. Arramraju, G.R. Mandala React@PCR moderator: J.F. Iglesias, J. Loh With continuous LIVE demonstration from Continental Hospitals, Hyderabad, India 11:40-11:55 _______________________________ Focus on Focus on left main interventions Chairpersons: M.C. Morice, P. Wong Panellists: M. Bedossa, P. Chandra, J.J. Cheng, C.Y. Chou, J.S. Hiremath, R.I. Low, M. Munawar, Q.T. Nguyen, S.J. Park g 15 mn My 10 keypoints on left main interventions - S.J. Park

P.J.L. Ong
g 10 mn New transradial interventional treatment: transradial

renal sympathetic denervation - J. Fajadet


g 10 mn Discussion & audience interaction g 3 mn Take-home message - M.C. Morice

___ 14:00-18:00 ____________________________________ Topic: CTO Attend these sessions if you want: g To be updated on techniques on antegrade and retrograde g To be updated on the equipment/materials used in coronary chronic total occlusion procedures 14:00-15:00 __________________________ LIVE demonstration LIVE demonstration from the National Heart Centre Singapore Chairpersons: S. Sumitsuji, A. Wong Panellists: W.H.N.S.C. Chan, K. Eisho, N. Inoue, W. Kehasukcharoen, M. Nakamura, T.K. Ong, S. Soerianata, B. Zhang Operators: E. Tsuchikane, K.K. Yeo React@PCR moderators: L.Y. Ping, L. Tay With continuous LIVE demonstration from the National Heart Centre Singapore
g 10 mn Pathology of coronary chronic total occlusion and its

influence on device selection - S. Sumitsuji

AsiaPCR/SingLIVE 2014 - Programme 25

SCIENTIFIC PROGRAMME

Programme
Friday 17th January, 2014 - Main arena
15:00-16:00 _________________________ LIVE demonstration LIVE demonstration from Continental Hospitals, Hyderabad, India Chairpersons: S. Sumitsuji, A. Wong Panellists: W.H.N.S.C. Chan, K. Eisho, N. Inoue, W. Kehasukcharoen, M. Nakamura, T.K. Ong, S. Soerianata, B. Zhang Operators: S.K. Arramraju, A. Salwan React@PCR moderators: L.Y. Ping, L. Tay With continuous LIVE demonstration from Continental Hospitals, Hyderabad, India 16:15-17:15 _________________________ LIVE demonstration LIVE demonstration from the National Heart Centre Singapore Chairpersons: S.T. Lim, W. Udayachalerm Panellists: K. Eisho, H.Y. Fang, Y. Hamazaki, P.M. Ku, A. Mehta, T. Muramatsu, S. Nakamura, N.Q. Nguyen, S. Rifqi, S. Saito Operators: M. Ochiai, K.L. Leow React@PCR moderators: L.Y. Ping, L. Tay With continuous LIVE demonstration from the National Heart Centre Singapore
g 10 mn Update on latest retrograde techniques 2014

ROOM 2 ___ 08:30-10:30 ____________________________ Plenary session Complications with fatal outcomes: India, Indonesia and Viet Nam With the collaboration of the National Interventional Council of India, the Indonesian Society of Interventional Cardiology and the Viet Nam Heart Association Chairpersons: S. Mishra, M. Munawar, T.N. Vo Panellists: S. Chour, T. Ghose, S. Redwood, K.H. Sim, A. Yearoo Attend this session if you want: g To learn how to manage coronary complications
g 10 mn Obstructed mitral valve prosthesis during core-valve

implantation: solum fortes superabunt - P. Chandra


g 3 mn Discussion & audience interaction g 10 mn Should we always comply to recommendations?

T.N. Vo
g 3 mn Discussion & audience interaction g 10 mn Acute tamponade, a complication of coronary CTO

PCI: how to deal with - S. Rifqi


g 4 mn Discussion & audience interaction g 10 mn Stent dislodgement in left main-left anterior

T. Muramatsu 17:15-17:55 _______________________________ Focus on Focus on wire selection Chairpersons: S.T. Lim, W. Udayachalerm Panellists: K. Eisho, H.Y. Fang, Y. Hamazaki, P.M. Ku, A. Mehta, T. Muramatsu, S. Nakamura, N.Q. Nguyen, S. Rifqi g 10 mn Wire selection (antegrade & retrograde) W. Udayachalerm g 10 mn How I select and cross collaterals - S. Nakamura g 10 mn Update on technique of antegrade wiring (wire shape, parallel, double lumen, catheter wiring) - K. Eisho g 10 mn Discussion & audience interaction 17:55-18:00 ____________________________Plenary session Wrap-up Chairpersons: S.T. Lim, W. Udayachalerm Panellists: K. Eisho, H.Y. Fang, Y. Hamazaki, P.M. Ku, A. Mehta, T. Muramatsu, S. Nakamura, N.Q. Nguyen, S. Rifqi g 5 mn Wrap-up by Ashwin Mehta End of the topic
g 3 mn g 10 mn g 4 mn g 10 mn

g 4 g 10 g 3 g 10

mn mn mn mn

g 3 mn

descending during percutaneous coronary intervention - H.T. Dung Discussion & audience interaction Right ventricular compression after complicated coronary chronic total occlusion intervention - L. Lison Discussion & audience interaction Complex retrieval of ventricular septal defect device for muscular ventricular septal defect veni, vidi, vici I. Vijayalakshmi Discussion & audience interaction Coronary perforation after stenting - Q.T. Nguyen Discussion & audience interaction Rotablator disassembly causing cardiogenic shock D. Firman Discussion & audience interaction

AsiaPCR/SingLIVE 2014 - Programme 26

SCIENTIFIC PROGRAMME

Friday 17th January, 2014 - Room 2


___ 10:45-12:00 ____________________________ Plenary session Practical PCI tips and tricks Chairpersons: A. Rahman, S.T. Lim Panellists: P.S. Banerjere, D.C.Y. Cheung, B. Garcia Del Blanco, D. Ghosh, J.Y. Han, M. Lim, G. Sengottuvelu Attend this session if you want: g To improve your skills by exchanging tips and tricks with peers
g 8 mn Successful transvenous intravascular ultrasound-

g 4 mn g 8 mn

g 4 mn g 8 mn g g g g g g 4 8 4 9 5 9 mn mn mn mn mn mn

g 5 mn

guided percutaneous coronary intervention of chronic total occlusion with a stent jail - A. Nozaki Discussion & audience interaction Successful case of PCI for left anterior descending proximal coronary chronic total occlusion with a modified homemade snare - Y. Kensuke Discussion & audience interaction Stent exchange in the left main coronary artery E. Merkulov Discussion & audience interaction Rendez-vous in a chronic total occlusion - P. Siegrist Discussion & audience interaction Management of balloon undilatable lesion - M. Ochiai Discussion & audience interaction A bailed out case of coronary perforation with microcatheter distal perfusion method - S. Ishihara Discussion & audience interaction

___ 14:00-16:00 ____________________________ Plenary session Techniques and devices targeting the sympathetic nervous system for hypertension control Chairpersons: S.T. Lim, F. Mahfoud Panellists: M. Choo, S. Cook, S. Hardt, V. Kumar, M. Lee, P.J.L. Ong Operators: C.T. Chin, S. Shetty Attend this session if you want: g To understand optimal patient selection g To be updated on the latest results g To understand how to perform a renal denervation procedure With continuous LIVE demonstration from the National Heart Centre Singapore
g 5 mn Introduction and objectives - F. Mahfoud g 12 mn Which resistant hypertension patients truly

g 12 mn

g 12 mn g 12 mn

g 10 mn g 10 mn

___ 12:35-13:55 ______________________________ Symposium Bioabsorbable polymers and drug eluting balloons: is the next step a fully absorbable magnesium scaffolds? With an unrestricted educational grant from Biotronik Se & Co KG Chairpersons: E. Eeckhout, S.T. Lim Panellists: U. Kaul, M.H. Jim Attend this session if you want: g To understand the characteristics of the Orsiro Sirolimus eluting stent with bioabsorbable polymer, its potential benefits and comparative clinical efficacy g To review the unique characteristics of the Pantera Lux DEB technology and its potential benefits for bifurcation lesions in an Asian population g To explore the potential benefits from an absorbable metallic scaffold
g 5 mn Introduction and objectives - S.T. Lim g 15 mn A novel DES with bioabsorbable polymer: the Orsiro g 15 mn g 15 mn g 15 mn g 10 mn g 5 mn

g 10 mn g 12 mn g 5 mn

deserve consideration for techniques targeting the sympathetic nervous system? - L.P. Low Background, anatomic and physiologic basis of device-based therapies targeting sympathetic system C.T. Chin Clinical data updates in 2014 - F. Mahfoud A quick glance of the currently available, or soon to be available, devices targeting sympathetic system J. Fajadet Debate on renal denervation therapy in Asia-Pacific region: It is grossly under-utilised and under-adopted S. Shetty Wait, dont fall prey to the hype - P.J.L. Ongg Unresolved issues and outlook - F. Mahfoud Take-home message - S.T. Lim

___ 16:15-18:00 ____________________________ Plenary session Haemodynamics support and therapeutic hypothermia Chairpersons: M. Noc, A. Wong Panellists: R.K. Abhaichand, P. Chandra, J.J. Cheng, J.F. Iglesias, J. Tan, M. Thomas, C.J. Wu Attend this session if you want: g To learn the various technical aspects of haemodynamics support using extra-corporeal membrane oxygenation (ECMO) and cooling g To understand the technical aspects of cooling g To understand the indications and complications of such devices
g 5 mn Overview - A. Wong g 8 mn Case presentation: intra-aortic balloon pumping in patient

Hybrid DES - E. Eeckhout Real world experience with bioabsorbable polymer DES - U. Kaul DEB experience in bifurcation lesions in an Asian population - M.H. Jim Bioabsorbable metal scaffold: programme status S.T. Lim Discussion & audience interaction Take-home message - E. Eeckhout

with high risk PCI or cardiogenic shock - M. Thomas


g 4 mn Discussion & audience interaction g 12 mn Role of intra-aortic balloon pumping in 2014 - P. Chandra g 8 mn Case presentation: rescue extra-corporeal membrane

oxygenation (ECMO) in cathlab - A. Wong


g 4 mn Discussion & audience interaction g 12 mn Extra-corporeal membrane oxygenation (ECMO) 1-0-1

(procedural steps and troubleshooting) - J.J. Cheng


g 8 mn Case presentation: cooling (case with comatose

survival of cardiac arrest) - J. Tan


g 4 mn Discussion & audience interaction g 12 mn Emerging role of cooling in myocardial salvage in

cardiogenic shock and acute myocardial infarction - M. Noc


g 20 mn Discussion & audience interaction g 8 mn Take-home message - M. Noc

AsiaPCR/SingLIVE 2014 - Programme 27

SCIENTIFIC PROGRAMME

Programme
Friday 17th January, 2014
ROOM 3

___ 08:30-09:30 _________________________________ Forum Forum: complications Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Chairperson: W. Wijns Panellists: D. Huy, L. Kalidoss, W. Kehasukcharoen, O. Maskon g 8 mn Overlapping drug eluting stent-bioresorbable scaffold PCI for chronic total occlusion and overlapping trouble - K.L. Yew g 4 mn Discussion & interaction g 8 mn A case of retrograde PCI for left anterior descending coronary chronic total occlusion complicated with a collateral channel injury - Y. Kensuke g 4 mn Discussion & interaction g 8 mn Trapped with no way out - M. Cardenas Manilla g 4 mn Discussion & interaction g 8 mn Beware of recrossing stent with rotablator wire E. Santos g 4 mn Discussion & interaction ___ 09:35-10:35 _________________________________ Forum Forum: TAVI Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions undefined Chairpersons: D. Tchtch, C.J. Wu Panellists: V. Chao, P. Chiam, M. Lee, T.T. Kyaing g 8 mn Transcatheter valve-in-valve intervention in a patient with prosthetic tricuspidal valve degeneration G.J. Friedrich g 4 mn Discussion & audience interaction g 8 mn A new method to manage coronary obstruction during TAVI - I. Mizote g 4 mn Discussion & audience interaction g 8 mn Misplacement of transcatheter aortic valve: how to treat it? Retrieval? Anchoring? - M. Bedossa g 4 mn Discussion & audience interaction g 8 mn Successful TAVI for a patient with moyamoya disease K. Maeda g 4 mn Discussion & audience interaction g 8 mn Successful transcatheter aortic valve replacement of severe aortic stenosis with small sinotubular junction by stepwise stent-valve dilatation and balloon repositioning - Y. Ichibori g 4 mn Discussion & audience interaction

___ 10:45-12:00 ____________________________ Abstract session Abstracts: structural Session comprising selected AsiaPCR/SingLIVE 2014 abstracts submissions Chairpersons: G. Guagliumi, M.K. Hong Panellists: C.H. Huang, B. Khoo, A. Menon, H. Trisnohadi, R. Tangco g 8 mn Early outcomes from percutaneous mitral valve repair with the MitraClip: multi-centre experience from the MitraClip Asia-Pacific Registry (MARS) - K.K. Yeo g 4 mn Discussion & audience interaction g 8 mn Transcatheter aortic valve implantation in Switzerland: early peri-procedural and 30-day outcomes from the National Swiss TAVI Registry - S. Stortecky g 4 mn Discussion & audience interaction g 8 mn Impact of b-Type natriuretic peptide and nt-pro-bType natriuretic peptide on clinical outcomes after transcatheter aortic valve implantation - S. Stortecky g 4 mn Discussion & audience interaction g 8 mn Impact of number of devices implanted on outcomes in the treatment of functional mitral regurgitation with MitraClip - D.N. Muda g 5 mn Discussion & audience interaction g 8 mn Two-year results of different TAVI techniques in high-risk patients: data from a single centre study R. Akchurin g 5 mn Discussion & audience interaction g 8 mn Is trans-apical approach really inferior to trans-femoral approach in TAVI procedure? - K. Torikai g 5 mn Discussion & audience interaction ___ 12:35-13:55 ______________________________ Symposium Dual therapy stent: an effective stent option With an unrestricted educational grant from OrbusNeich Medical Pte Ltd. Chairperson: H. Suryapranata Panellists: G. De Luca, S. Lee, T. Santoso, D. Tresukosol, A. Wong Attend this session if you want: g To obtain latest clinical results data of dual therapy stent g To understand the dual therapy stent experience around the region
g 10 mn Introduction and objectives - H. Suryapranata g 20 mn Dual therapy stent: clinical evidence for durable

results - S. Lee
g 20 mn DAPT duration for ACS patients - G. De Luca g 15 mn Singapore single center experience with dual therapy

stent - A. Wong
g 10 mn Discussion & audience interaction g 5 mn Take-home message - H. Suryapranata

AsiaPCR/SingLIVE 2014 - Programme 28

SCIENTIFIC PROGRAMME

Friday 17th January, 2014 - Room 3


___ 14:00-15:00 ____________________________ Abstract session Abstracts: imaging Session comprising selected AsiaPCR/SingLIVE 2014 abstracts submissions Chairpersons: T. Akasaka, M. Rosenberg Panellists: D. Bhattacharya, R.N. Chakraborty, Y.H. Kim, C.S. Tan, T.N. Vo g 8 mn Intravascular ultrasound iMAP for radiofrequency data analysis: in vivo the cathlab - G. Pimentel Morales g 4 mn Discussion & audience interaction g 8 mn Clinical outcomes of an original preoperative computer tomoraphy assessment of transcatheter aortic valve implantation for Asian patients of small body size - K. Maeda g 4 mn Discussion & audience interaction g 8 mn Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at patient level of four registries - J.M. De La Torre Hernandez g 4 mn Discussion & audience interaction g 8 mn Assessment of coronary artery calcification on fractional flow reserve in intermediate stenotic lesions K. Horie g 4 mn Discussion & audience interaction g 8 mn The reliability and efficacy of our novel software, simulating terittories of myocardium at risk based on multidetector-row computer tomoraphy data sets - S. Ide g 4 mn Discussion & audience interaction ___ 15:05-16:00 _________________________________ Forum Forum: PCI cases Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Chairpersons: R.M. Ali, J.M. De La Torre Hernandez Panellists: T. Cuisset, F.Y. Kuo, T.N. Nguyen, N. Nwe, W. Santharaj g 7 mn Thrombus in primary PCI for acute myocardial infarction: is it worth to aspirate after stenting? N.Q. Nguyen g 4 mn Discussion & audience interaction g 7 mn Single guider retrograde percutaneous coronary intervention of a proximal right coronary artery chronic total occlusion using bridging epicardial collateral - B.W.M. Liew g 4 mn Discussion & audience interaction g 7 mn Can we attempt PCI guide wire to open occluded coronaries through diagnostic catheters without changing to guiding catheters in untoward circumstances? A case report of guide less PCI J.R. Babburi g 4 mn Discussion & audience interaction g 7 mn Acute myocardial infarction complicated by cardiogenic shock in a patient with Leriche syndrome - Y. Kakefuda g 4 mn Discussion & audience interaction ___ 16:15-17:45 _________________________________ Forum Forum: complications Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Chairpersons: J. Monsgu, R. Zambahari Panellists: M. Kumar, S.W. Kyaw, A. Mahilmaran, B.Y. Setianto g 8 mn Corsair and guidewire complication: entrapment, fracture and successful retrieval - E. Santos g 4 mn Discussion & audience interaction g 9 mn All inclusive (stent distortion, artery damage, thrombosis, extravasation, myocardial infarction) - E. Merkulov g 4 mn Discussion & audience interaction g 9 mn Primary percutaneous intervention: watch your guide catheter - S. Narayanan g 4 mn Discussion & audience interaction g 9 mn From a doubtful indication to a Swiss complication cascade - J.F. Iglesias g 4 mn Discussion & audience interaction g 9 mn Complications of PCI for right coronary artery coronary chronic total occlusion lesion: left ventricular dislodged stent and aortocoronary dissection - C.C. Hung g 4 mn Discussion & audience interaction g 9 mn Percutaneous transluminal coronary angioplasty of acute iatrogenic occlusion of left main, during cardiac arrest - R. Bhardwaj g 4 mn Discussion & audience interaction g 9 mn Repeat subacute re-occlusion of right coronary artery coronary chronic total occlusion lesion post PCI W.C. Huang g 4 mn Discussion & audience interaction

AsiaPCR/SingLIVE 2014 - Programme 29

SCIENTIFIC PROGRAMME

Programme
Friday 17th January, 2014
ROOM 4 ___ 08:30-09:30 ____________________________ Plenary session Percutaneous edge-to-edge mitral valve repair Chairpersons: R.I. Low, K.K. Yeo Panellists: Z.P. Ding, D.N. Muda, N.Q. Nguyen, Y.K.K. Sin Attend this session if you want: g To learn about the indications and patient selection for the MitraClip procedure g To understand how the procedure is performed
g 10 mn Step-by-step - D.N. Muda g 10 mn Update on data - R.I. Low g 10 mn Imaging for MitraClip: case selection considerations

___ 10:45-12:00 _____________________________________ Learning complex bifurcation: two-stent technique Facilitators: J. Fajadet, C.K. Naber, A. Wong Attend this session if you want: g To better estimate which two-stent bifurcation technique to use for which patient g To better review with experts how to perform the different two-stent techniques ___ 14:00-16:00 _____________________________________ Learning transradial interventions Facilitators: B. Farah, J. Monsgu, J. Tan Resource experts: L. Bilodeau, S. Saito Media driver: D. Yong Attend this session if you want: g To cover the fundamentals of the transradial approach in order to start a radial programme g To safely navigate and resolve potential difficulties from the radial artery to the ascending aorta g To know how to choose and manipulate catheters for angiography and PCI

and procedural steps - Z.P. Ding


g 10 mn MitraClip patient selection: the good, the bad and the

ugly - R.I. Low


g 10 mn Update on Asia-Pacific MitraClip data: MARS registry

K.K. Yeo
g 10 mn Case presentation - R. Zambahari

___ 09:35-10:30 ____________________________ Plenary session Left atrial appendage closure Chairpersons: T.H. Koh, C.K. Naber Panellists: Z.P. Ding, M. Nguyen Attend this session if you want: g To learn the indications and evidence for left atrial appendage closure g To gain knowledge of the different devices
g 2 g 20 g 10 g 10

Introduction - C.K. Naber Recorded LIVE demonstration - T.H. Koh Evidence for left atrial appendage closure - C.K. Naber Imaging evaluation of left atrial appendage closure Z.P. Ding g 10 mn Choice of device for patients with indications for left atrial appendage closure - C.K. Naber g 3 mn Take-home message - T.H. Koh
mn mn mn mn

___ 16:15-18:00 ____________________________ Plenary session Nurses, technicians and radiographer - Part II Facilitators: C.T. Chin, V. Kwok Panellists: N. Nutcharee, C. Saraswathy, S. Sundrasenan, K. Yau Tung Wai Attend this session if you want: g To identify and manage complications g To learn the technical aspects of the device preparations g To anticipate technical issues during PCI
g 5 g 10 g 10 g 10 g 10 mn mn mn mn mn

g 10 mn g 10 mn g 20 mn g 5 mn

Introduction - C.T. Chin Radiation protection - S. Srimahachota Approach to STEMI procedures - T. Teo Temporary pacing - K.H. Chee Understanding haemodynamics in the cathlab M. Nguyen Cardiac views and projections: which part of the anatomy, which angle, tips and tricks - T.H. Koh How to be a great scrub nurse assistant: tips & tricks S. Sundrasenan Discussion & audience interaction Wrap-up - V. Kwok

AsiaPCR/SingLIVE 2014 - Programme 30

SCIENTIFIC PROGRAMME

Friday 17th January, 2014


INTERACTIVE CASE CORNER ___ 09:00-10:30 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: S. Khan, S. Nakamura g PCI of left main coronary artery, left anterior descending and percutaneous transluminal angioplasty with stenting of right external iliac artery to common femoral artery in unusual clinical setting - K. Sridhar g A BMS deformation caused by the aspiration catheter passed between the vessel wall and the previous stent - Y. Akita g Get friendly with guide liner - R. Chawla g Transradial left main trifurcation stenting - V. Kumar g Provisional T-stenting in tortuous side branch using Sidewinder technique - Y. Katagiri g Three vessels complete revascularisation using trans-radial 5 French catheter in a case of non-ST elevation myocardial infarction - L.C. Chen ___ 10:45-12:00 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: R.N. Chakraborty, S. Khan, S. Nakamura g WIRE FIRST technique during PTCA to right internal mammary to right coronary artery graft anastomotic site T. Ghose g Renal and trifurcation stenting for patient with chronic kidney disease - K. Sridhar g Deception point - K. Bhatt g Keeping focused on the rush - M. Cardenas Manilla g Unprotected left main laser atherectomy - D. Goyal ___ 14:00-14:40 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: N. Chouhan, R.I. Low, R. Zambahari g Interesting angio finding of acute recoiling of post bioresorbable scaffold deployment - K.K. Chanakya g Multilevel vascular aneurysms and polycystic kidney disease S. Degrauwe g A challenging case of primary PCI in a patient with recurrent ventricular fibrillation and giant right coronary artery aneurysm - D. Goyal ___ 14:45-16:00 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: R.I. Low, T. Selvan g Snaring of an embolised stent - Y. Shiva Kumar g How we manage to overcome an unexpected situation L. Kapuruge g Simultaneous PCI of bifurcation of distal right coronary artery and percutaneous transluminal angioplasty (PTA) of near total occlusion of left internal carotid artery - K. Sridhar g Retrieval of an embolized guidewire six months following the embolization episode - T. Ghose g Never quit certainty for hope - V. Mironov g Anomalous origin of left circumflex from RT sinus of Valsalva Y. Raju ___ 16:15-17:30 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: B. Chua, N. Khanna, K.K. Yeo g Chimney aortic stent graft with renal, iliac artery stenting for complicated type B aortic dissection and malperfusion syndrome - J.S. Park g Percutaneous bifurcation stent grafting of abdominal aorta for ruptured aneurysm with retroperitoneal haematoma K. Sridhar g Endovascular treatment of complicated type B aortic dissection and malperfusion syndrome in the distal aorta J.S. Park g Takayasu aortitis patient with right common carotid artery and left subclavian artery total occlusion - K. Sridhar

AsiaPCR/SingLIVE 2014 - Programme 31

SCIENTIFIC PROGRAMME

Programme
Friday 17th January, 2014

PERIPHERAL PROGRAMME
3rd FLOOR ___ 08:30-10:30 ____________________________ Plenary session Superficial femoral artery and below knee intervention Chairpersons: B. Chua, M. Nakamura Panellists: C.I. Cheng, S.W. Rha g 5 mn Introduction and objectives - M. Nakamura g 12 mn Key points to know about non-invasive evaluation (Duplex, coronary computed tomography angiography, magnetic resonance angiography) of lower limb arterial disease g 12 mn Toolkits (sheaths, catheters, guidewires) for superficial femoral artery and below the knee angioplasty, including coronary CTOs - S.W. Rha g 12 mn New stents, scaffolds and drug-coated-balloons for superficial femoral artery and below the knee angioplasty. Are they really useful? - N. Khanna g 8 mn A case of endovascular treatment for total occlusion of superficial femoral artery using multifunction catheter - D. Yokota g 4 mn Discussion & audience interaction g 12 mn Superficial femoral artery coronary CTO interventions case presentation (combined antegrade/retrograde approach) - M. Nakamura g 12 mn No stent zone (common femoral artery and behind knee): what to do? - B. Chua
g 12 mn Tips and tricks of popliteal and below knee vascular

access with case examples - M. Nakamura


g 12 mn My teaching case of below the knee interventions

S.W. Rha
g 12 mn Top essential things to know about critical limb

ischemia management - N. Khanna


g 7 mn Discussion & audience interaction

___ 10:45-12:00 ____________________________ Plenary session My most educational case in peripheral intervention Chairpersons: P. Chiam, M. Nakamura Panellists: B. Chua, N. Khanna, M. Nguyen, S.W. Rha, M. Taneja g 12 mn Case 1 (carotid/subclavian) - S.W. Rha g 3 mn Discussion & audience interaction g 12 mn Case 2 (below the knee) - M. Nakamura g 3 mn Discussion & audience interaction g 12 mn Case 3 (lower limb) - B. Chua g 3 mn Discussion & audience interaction g 12 mn Case 4 - L. Thosaphol g 3 mn Discussion & audience interaction g 12 mn Case 5 (superficial femoral artery/renal) - N. Khanna g 3 mn Discussion & audience interaction

SPECIAL WORKSHOPS
3rd FLOOR ___ 14:00-15:00 _______________________________ Workshop IVUS workshop Facilitators: K.T. Chan, M.K. Hong, J. Honye g 25 mn IVUS: image interpretation - J. Honye g 12 mn IVUS: measurement - M.K. Hong g 12 mn IVUS: common IVUS image artefact - K.T. Chan g 11 mn Discussion & audience interaction ___ 15:05-16:00 _______________________________ Workshop FFR workshop: Step-by-step, common pitfalls and complex lesion subsets Facilitators: W. Buddhari, K.W. Ho, J.F. Iglesias, A. Low g 15 mn Step-by-step guide of performing FFR properly and hyperemic agents - K.W. Ho g 15 mn Common pitfalls during FFR measurement and situations where FFR may not be accurate - A. Low g 15 mn FFR in complex lesion subset (specifically long diffuse/ multiple lesions, ostial, left main and ACS-culprit and non-culprit lesions, hypertrophic cardiomyopathy) W. Buddhari g 5 mn Discussion & audience interaction ___ 16:15-17:15 _______________________________ Workshop OCT workshop: image interpretation, measurement and common artifacts Facilitators: T. Akasaka, G. Guagliumi, S. Lee g 20 mn OCT: image Interpretation incorporating Clinical atlas of intravascular OCT - T. Akasaka g 15 mn Tip and trick in getting good OCT images - S. Lee g 15 mn OCT: common OCT image artefact and some rare OCT images - G. Guagliumi g 10 mn Discussion & audience interaction

AsiaPCR/SingLIVE 2014 - Programme 32

SCIENTIFIC PROGRAMME

Friday 17th January, 2014

TRAINING WORKSHOPS
BOSTON SCIENTIFIC TRAINING ROOM ___ 09:00-12:00 _____________________________________ ___ 13:00-17:00 _____________________________________ Interactive workshop: rotablator atherectomy system, Vessix renal denervation system and IVUS - iLAB imaging system With an unrestricted educational grant from Boston Scientific Attend this session if you want: g To have hands-on training on the use of Rotablator in wetheart model g To have hands-on training on the use of Vessix Renal Denervation System g To have hands-on training on the use of iLAB imaging System
g Rotablator atherectomy system: pre-treating calcified lesions

MEDTRONIC TRAINING ROOM ___ 08:30-12:00 _____________________________________ ___ 12:30-17:30 _____________________________________ Innovation lab: learning with next generation devices and therapies With an unrestricted educational grant from Medtronic Attend this session if you want: g To learn with next generation devices and therapies
g Simulator training on Medtronic next generation Spyral

catheter for resistant hypertension treatment


g A look into Medtronic next generation stent development

and coronary product pipeline presentation

with rotational atherectomy can be one of the best way to enhance proper stent placement. The Rotablator System provides an excellent option for treating calcified lesions, with a complete family of products g Vessix renal denervation system: designed to reduce blood pressure in resistant hypertensive patients while offering the familiarity of an over-the-wire balloon catheter, the precision of bipolar energy delivery in the shortest treatment time g IVUS -iLAB Imaging System: IVUS (Intravascular Ultrasound) is a catheter-based system that provides a dramatic improvement in the diagnosis and management of coronary artery disease

AsiaPCR/SingLIVE 2014 - Programme 33

SCIENTIFIC PROGRAMME

Programme
Saturday 18th January, 2014
MAIN ARENA ___ 08:30-11:45 ____________________________________

Closing ceremony
___ 11:45-11:55 ___________________________ Plenary session Closing ceremony Chairpersons: E. Eeckhout, T.H. Koh Panellists: J. Fajadet, S.T. Lim, M.C. Morice, C.K. Naber, P.W. Serruys, A. Wong

Topic: Transradial
Attend these sessions if you want: g To appreciate the applicability and limitations of transradial intervention for complex interventions g To understand how to overcome anatomical and procedural difficulties 08:30-09:25 _________________________ LIVE demonstration LIVE demonstration from Siriraj Hospital, Bangkok, Thailand Chairpersons: C.K. Naber, W. Udayachalerm Panellists: N. Ahmed, L. Bilodeau, P. Chiam, W.Y. Guo, M. Nguyen, M. Rosenberg, O. Varenne, A.F. Yahya Operator: D. Tresukosol React@PCR moderator: J.K.B. Tan With continuous LIVE demonstration from Siriraj Hospital, Bangkok, Thailand

New this year!


___ 11:55-14:00 ____________________________________ Lunch with Course Directors You are all invited to join a lunch buffet with the Course Directors in the exhibition area

Award ceremony
___ 09:25-09:40 ___________________________ Plenary session Presentation of 2014 awards Chairpersons: C.K. Naber, W. Udayachalerm Panellists: N. Ahmed, L. Bilodeau, P. Chiam, W.Y. Guo, M. Nguyen, M. Rosenberg, O. Varenne, A.F. Yahya g 7 mn AsiaPCR/SingLIVE best abstracts - E. Eeckhout g 3 mn AsiaPCR/SingLIVE best clinical case - T.H. Koh g 5 mn Presentation of the best clinical case of the year

09:40-10:30 _________________________ LIVE demonstration LIVE demonstration from the National Heart Centre Singapore Chairpersons: C.K. Naber, W. Udayachalerm Panellists: N. Ahmed, L. Bilodeau, P. Chiam, W.Y. Guo, M. Nguyen, M. Rosenberg, O. Varenne, A.F. Yahya Operators: J.M. Fam, A. Wong React@PCR moderator: J.K.B. Tan With continuous LIVE demonstration from the National Heart Centre Singapore 10:45-11:45 _________________________ LIVE demonstration LIVE demonstration from Siriraj Hospital, Bangkok, Thailand Chairpersons: E. Eeckhout, T.H. Koh Panellists: J. Fajadet, S.T. Lim, M.C. Morice, C.K. Naber, P.W. Serruys, A. Wong , C.J. Wu Operator: D. Tresukosol React@PCR moderator: J.K.B. Tan With continuous LIVE demonstration from Siriraj Hospital, Bangkok, Thailand End of the topic

AsiaPCR/SingLIVE 2014 - Programme 34

SCIENTIFIC PROGRAMME

Saturday 18th January, 2014


ROOM 2 ___ 08:30-10:00 ____________________________ Plenary session Invasive imaging and physiology (IVUS/OCT/FFR)- Part I Chairpersons: T. Akasaka, M.K. Hong, A. Low Panellists: K.T. Chan, N. Chouhan, J. Honye, S.H. Hur, R.C.H Lee Attend this session if you want: g To be convinced that some coronary interventions cannot be performed without pure angiographic guidance g To understand the indications and role of FFR, IVUS, OCT g 1 mn Introduction and objectives g 10 mn Can we really detect clinically relevant vulnerable plaques by imaging? - P.W. Serruys g 10 mn What is known about the OCT-detected neoatherosclerosis? - M.K. Hong g 8 mn The story of a young man and his heart ache - D. Banik g 4 mn Discussion & audience interaction g 10 mn Practical step-by-step IVUS guide to wiring of coronary chronic total occlusion with proximal occlusion next to a side-branch and identification of true versus subintimal lumens - S. Sumitsuji g 8 mn Interesting IVUS images of an uncommon clinical condition - M. Teramura g 4 mn Discussion & audience interaction g 10 mn Debate on iFR (protagonist): It is the way to go? - W. Hau g 10 mn Debate on iFR (antogonist): Wait, there are still too many unknows - T. Akasaka g 15 mn IVUS quiz - M.K. Hong ___ 10:15-11:45 ____________________________ Plenary session Invasive imaging and physiology (IVUS/OCT/FFR) - Part II Chairpersons: T. Akasaka, G. Guagliumi, M.K. Hong Panellists: K.H. Chee, K. Cheng, W.Y. Chung, J. Honye Attend this session if you want: g To learn about new emerging imaging technologies g 10 mn Combining anatomy and physiology in left main intervention strategy - S.J. Park g 8 mn OCT follow-up of stents. Is this worrisome? G. Sengottuvelu g 4 mn Discussion & audience interaction g 10 mn The incidence, predictors and clinical outcomes of acute and late stent malapposition detected by OCT after DES implantation - M.K. Hong g 15 mn OCT Quiz - G. Guagliumi g 10 mn Common mistakes/pitfalls made with OCT - T. Akasaka g 5 mn Quick technology update: what is in the pipeline for Boston Scientific IVUS solutions - J. Honye g 5 mn Quick technology update: what is in the pipeline for St Jude Medical OCT/FFR solutions - D. Wong g 5 mn Quick technology update: what is in the pipeline for St Jude Medical OCT/FFR solutions - S. Chakraborty g 10 mn 10 facts every interventional cardiologist should know about invasive and non-invasive coronary imaging G. Guagliumi g 5 mn Quick technology update: what is in the pipeline for Terumo IVUS/OCT solutions - T. Akasaka g 3 mn Take-home message - T. Akasaka INTERACTIVE CASE CORNER ___ 08:30-09:30 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: S. Khan, S.C. Ng g PCI to multiplecoronary chronic total occlusion lesions by left radial approach with high grade subclavian tortuosity S.R. Khan g Bioresorbable vascular scaffold deployment in left main L. Jha g Anomalous right coronary artery ostial lesion percutaneous transluminal coronary angioplasty with stent (Elephant trunk technique) - A. Tumkur g Left main PCI in acute extensive anterior wall STEMI M. Chopra g Strategy for an acute myocardial infarction with multi vessel disease: contribution of IVUS and FFR - M. Bedossa ___ 09:35-10:35 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: S. Khan, S.C. Ng g Subacute stent thrombosis - S. Narayanan g Successful PCI in patients with acute coronary syndrome and anomalous origin of coronary artery - J.Y. Han g An unusual case of large left ventricular myxoma extending through aortic valve presented in a young male with antero-septal myocardial infarction - J.R. Babburi g OCT guided coronary chronic total occlusion of left anterior descending with bioresorbable scaffolds - K. Sridhar g Dedicated bifurcation stent - K. Sheth g LT main recanalization in a young girl with Takayasus arteritis V. Kumar g To stent or not to stent, that is the question - C.W. Wong ___ 10:45-11:45 _____________________________________ Session comprising selected AsiaPCR/SingLIVE 2014 clinical cases submissions Facilitators: R.M. Ali, P. Chiam, K. Hayashida g Disappearance of left anterior descending muscle bridge post alcohol septal ablation in hypertrophic obstructive cardiomyopathy (HOCM) - K.K. Chanakya g Successful TAVI and CABG off-pump in 91 years old patient with severe aortic stenosis and coronary artery disease R. Akchurin g A conventional electrophysiological catheter-based renal denervation in chronic kidney disease patient: dont give up, it still has a chance! - H.B. Tran

AsiaPCR/SingLIVE 2014 - Programme 35

SCIENTIFIC PROGRAMME

Programme
Saturday 18th January, 2014

TRAINING WORKSHOPS
BOSTON SCIENTIFIC TRAINING ROOM ___ 09:00-12:00 _____________________________________ Interactive workshop: rotablator atherectomy system, Vessix renal denervation system and IVUS - iLAB imaging system With an unrestricted educational grant from Boston Scientific Attend this session if you want: g To have hands-on training on the use of Rotablator in wetheart model g To have hands-on training on the use of Vessix Renal Denervation System g To have hands-on training on the use of iLAB imaging System
g Rotablator atherectomy system: pre-treating calcified lesions

MEDTRONIC TRAINING ROOM ___ 08:30-12:00 _____________________________________ Innovation lab: learning with next generation devices and therapies With an unrestricted educational grant from Medtronic Attend this session if you want: g To learn with next generation devices and therapies
g Simulator training on Medtronic next generation Spyral

catheter for resistant hypertension treatment


g A look into Medtronic next generation stent development

and coronary product pipeline presentation

with rotational atherectomy can be one of the best way to enhance proper stent placement. The Rotablator System provides an excellent option for treating calcified lesions, with a complete family of products g Vessix renal denervation system: designed to reduce blood pressure in resistant hypertensive patients while offering the familiarity of an over-the-wire balloon catheter, the precision of bipolar energy delivery in the shortest treatment time g IVUS -iLAB Imaging System: IVUS (Intravascular Ultrasound) is a catheter-based system that provides a dramatic improvement in the diagnosis and management of coronary artery disease

AsiaPCR/SingLIVE 2014 - Programme 36

POSTER GALLERY

Dont miss the abstract posters!


We would like to thank all the 2014 abstracts submitters. From the 91 submissions, we are pleased to list the abstracts selected for display in the Posters Gallery.

POS01
Abbreviated vs. standard eptifibatide infusion in STEMI Outcomes and predictors of complications Dr BAGHERLI A., University of Manitoba, WINNIPEG, CANADA

trial comparing Sirolimus-eluting stents with Zotarolimuseluting stents for the treatment of total coronary occlusions Dr TEEUWEN K., Dr SUTTORP M.J., St. Antonius Hospital, NIEUWEGEIN, THE NETHERLANDS

POS02
Two-year clinical outcomes according to the complete or incomplete revascularisation in patients with chronic total occlusion - Korean E-CTO registry Dr PARK W., Dr KIM H.J., DongKang medical center, ULSAN, SOUTH KOREA; Prof KIM U., Prof PARK J.S., Prof SHIN D.G., Prof KIM Y.J., Yeungnam university medical center, DAEGU, SOUTH KOREA

POS10
c-arm fluoroscopy imaging combined with intracardiac echo and preprocedural computer tomography in transcatheter aortic valve interventions: a safe and feasible procedure in the operating room? Prof FRIEDRICH G., Prof BARTEL T., Dr MUELLER S., Prof MUELLER L., Prof SCHACHNER T., Prof VELIK-SALCHNER C., Prof FEUCHTNER G., Prof BONAROS N., Medical University Innsbruck, INNSBRUCK, AUSTRIA

POS03
Favourable results of PCI of unprotected left main with a one stent strategy and Syntax Score<33 Dr VAN BOVEN A., Medisch Centrum Leeuwarden, LEEUWARDEN, THE NETHERLANDS

POS11
Is a high Syntax Score associated with occurrence of more outcomes in unprotected left main coronary artery disease? Dr HATTAB M., Dr HAKIM M., Dr CARREIRA BRANDAO V., Dr ELHADAD S., Hopital Marne La Valle, JOSSIGNY, FRANCE

POS04
Use of 5 F vs. 6 F guide catheter by left transradial approach for coronary intervention in diabetic population Dr KHAN S.R., Ibrahim cardiac Hospital and research institute, DHAKA, BANGLADESH

POS12
Short and intermediate term outcome of percutaneous intervention to coronary artery bypass grafts Dr RAYMOND R., Ain Shams university, CAIRO, EGYPT

POS05
Endovascular treatment in patients with complicated type B aortic dissection and malperfusion syndrome: mid-term results from a single centre Dr PARK J.S., Prof LEE H.C., Dr KIM J.H., Prof LEE H.W., Prof OH J.H., Prof CHA K.S., Prof HONG T.J., Pusan National University Hospital, BUSAN, SOUTH KOREA; Dr CHOI J.H., Busan Medical Center, BUSAN, SOUTH KOREA

POS13
The management strategies of STEMI patients in Russian Federation during 2010-2012 period according to National Acute Coronary Syndrome Registry Prof RUDENKO B., Dr SHANOYAN A., Prof BOYTSOV S., Russian National Center for Preventive Medicine, MOSCOW, RUSSIAN FEDERATION

POS14
Carotid interventions in standard and high surgical risk patients with concomitant coronary artery disease Prof RUDENKO B., Dr SHANOYAN A., Prof BOYTSOV S., Russian National Center for Preventive Medicine, MOSCOW, RUSSIAN FEDERATION; Dr BOLOTOV P., Moscow City Hospital N 81, MOSCOW, RUSSIAN FEDERATION

POS06
Effect and safety of adipose tissue-derived stem cell implantation in critical limb ischemia Dr PARK J.S., Prof LEE H.C., Dr KIM J.H., Dr LEE W.L., Prof OH J.H., Prof CHA K.S., Prof HONG T.J., Pusan National University Hospital, BUSAN, SOUTH KOREA; Dr CHOI J.H., Busan Medical Center, BUSAN, SOUTH KOREA

POS07
Endovascular aortic repair of ruptured thoracic aorta pathology: mid-term results from a single centre Dr PARK J.S., Prof LEE H.C., Dr KIM J.H., Prof LEE H.W., Prof OH J.H., Prof CHA K.S., Prof HONG T.J., Pusan National University Hospital, BUSAN, SOUTH KOREA; Dr CHOI J.H., Busan Medical Center, BUSAN, SOUTH KOREA

POS15
Definition of myocardial viability as an important predictor of favorable prognosis of patients with stable angina after PCI Dr SHUGUSHEV Z.K., Dr PATRIKEEV A.V., Dr MAXIMKIN D.A., Dr STUROV N.V., Dr RUDMAN V.Y., Peoples Friendship University of Russia, MOSCOW, RUSSIAN FEDERATION

POS08
Development of a novel, fenestrated aortic arch stent graft with preloading catheter to protecting branch arteries: an experimental study in the swine Prof LEE H.C., Dr PARK J.S., Dr KIM J.H., Prof LEE H.W., Prof OH J.H., Prof CHA K.S., Prof HONG T.J., Pusan National University Hospital, BUSAN, SOUTH KOREA; Dr CHOI J.H., Busan Medical Center, BUSAN, SOUTH KOREA

POS16
The modern view of medical providing PCI in patients with acute coronary syndrome Dr MAXIMKIN D.A., Dr SHUGUSHEV Z.K., Peoples Friendship University of Russia, MOSCOW, RUSSIAN FEDERATION

POS17
Angiographic outcomes of drug-eluting balloon in bifurcation lesions: the SARPEDON study Ms KHOONG F.E., BIOTRONIK Asia Pacific Pte Ltd, SINGAPORE, SINGAPORE, Dr JIM M.H., Grantham Hospital, HONG KONG, HONG KONG

POS09
Three-year clinical outcomes in the primary stenting of totally occluded native coronary arteries III (PRISON III) - Randomised

AsiaPCR/SingLIVE 2014 - Programme 37

POSTER GALLERY

POS18
The relationship between routine laboratory parameters with the degree of coronary artery stenosis: preliminary study Dr SETIADI B., Dr KRISTIAN H., Dr BUDIONO B., Dr PANDA L., Prof LEFRANDT R., Dr PANGEMANAN J., Sam Ratulangi University, MANADO, INDONESIA

POS27
Short term outcome of drug-eluting stent implantation in the femoropopliteal segment Dr TSUTSUMI M., Dr MURAMATSU T., Dr TSUKAHARA R., Dr ITO Y., Dr ISHIMORI H., Dr HIRANO K., Dr NAKANO M., Dr ARAKI M., Dr KATO T., Dr KOBAYASHI N., Dr TAKIMURA H., Dr SAKAMOTO Y., Dr ISHII A., Dr TAKAMA T., Dr TAKAFUJI H., Dr TOKUDA T., Dr MAKINO K., Saiseikai Yokohama-City Eastern Hospital, YOKOHAMA, JAPAN

POS19
Intracoronary bolus compared with intravenous standard clotinab infusion during PCI in patients with acute coronary syndrome Dr LEE S.R., Chonbuk National University Hospital, JEONJU, SOUTH KOREA

POS28
Plaque debris is higher risk of distal embolisation compared with thrombus during PCI Dr MATSUO K., Osaka Police Hospital, OSAKA, JAPAN

POS20
Addressing barriers for optimising STEMI care systems in Sri Lanka: a pilot study to measure treatment times and survival following primary PCI for acute STEMI Dr RANASINGHE G., General Hospital Kalutara, KALUTARA, SRI LANKA; Dr SANTHARAJ W., Institute of Cardiology, COLOMBO, SRI LANKA; Dr KITSIRI R., Medical Research Assistant, COLOMBO, SRI LANKA

POS29
Clinical outcome of drug-eluting stents for diabetic patients femoropopliteal disease Dr TSUTSUMI M., Dr MURAMATSU T., Dr TSUKAHARA R., Dr ITO Y., Dr ISHIMORI H., Dr HIRANO K., Dr NAKANO M., Dr ARAKI M., Dr KATO T., Dr KOBAYASHI N., Dr TAKIMURA H., Dr SAKAMOTO Y., Dr MORI S., Dr ISHII A., Dr TAKAMA T., Dr TAKAFUJI H., Dr TOKUDA T., Dr MAKINO K., Saiseikai Yokohama-City Eastern Hospital, YOKOHAMA, JAPAN

POS21
Haemostasis using a percutaneous suture-mediated closure device without presuturing for removing the large-bore cannula used for percutaneous cardiopulmonary bypass Mr YASUHIRO T., The Fratenity Mermorial Hospital, TOKYO, JAPAN

POS30
Impact of renal insufficiency on major adverse cardiovascular events in patients undergoing PCI with Everolimus-eluting stent Dr DAN K., Dr NAKAHAMA M., Dr KAGAWA K., Dr NAITO Y., Fukuyama City Hospital, FUKUYAMA, JAPAN

POS22
Outcome of transradial primary angioplasty in octogenarians - A single centre experience in Asian patients Dr GHOSE T., Dr KACHRU R., Dr GUPTA R., Dr HUSSAIN A., Dr BHATT D., Dr MISHRA A., Dr SUD R., Dr KAUL U., Fortis Flt. Lt. Rajan Dhall Hospital, NEW DELHI, INDIA

POS31
The outcome of drug-eluting stent for true ostial lesion of right coronary artery Dr MORI S., Dr MURAMATSU T., Dr TSUKAHARA R., Dr ITO Y., Dr ISHIMORI H., Dr HIRANO K., Dr NAKANO M., Dr YAMAWAKI M., Dr ARAKI M., Dr KATO T., Dr KOBAYASHI N., Dr TAKIMURA H., Dr SAKAMOTO Y., Dr TSUTSUMI M., Dr TAKAMA T., Dr TAKAFUJI H., Dr TOKUDA T., Dr MAKINO K., Saiseikai Yokohama-City Eastern Hospital, YOKOHAMA, JAPAN

POS23
Initial experience with bioresorbable vascular scaffold (BVS) system in primary PCI angioplasty through transradial route Dr HUSSAIN A., Fortis Flt. Lt. Rajan Dhall Hospital, NEW DELHI, INDIA

POS32
Short-term result of Paclitaxel-eluting stents for TransAtlantic InterSociety Consensus (TASC) II class C or D superficial femoral arterial lesions Dr MORI S., Dr MURAMATSU T., Dr TSUKAHARA R., Dr ITO Y., Dr ISHIMORI H., Dr HIRANO K., Dr NAKANO M., Dr YAMAWAKI M., Dr ARAKI M., Dr KATO T., Dr KOBAYASHI N., Dr TAKIMURA H., Dr TSUTSUMI M., Dr TAKAMA T., Dr TAKAFUJI H., Dr TOKUDA T., Dr MAKINO K., Saiseikai Yokohama-City Eastern Hospital, YOKOHAMA, JAPAN

POS24
Usefulness of Allens test and pulse oximetry test in predicting artery with the larger diameter before coronary angiography and intervention Dr SUPIT A., Dr BUDIONO B., Sam Ratulangi University Manado/ Heart and Vascular Centre Awal Bros Hospital Makassar, MANADO, INDONESIA; Dr PANGEMANAN J., Prof LEFRANDT R., Sam Ratulangi University, MANADO, INDONESIA

POS33
Short-term results of endovascular treatment for isolated common femoral artery disease Dr MORI S., Dr MURAMATSU T., Dr TSUKAHARA R., Dr ITO Y., Dr ISHIMORI H., Dr HIRANO K., Dr NAKANO M., Dr YAMAWAKI M., Dr ARAKI M., Dr KATO T., Dr KOBAYASHI N., Dr TAKIMURA H., Dr SAKAMOTO Y., Dr TSUTSUMI M., Dr TAKAMA T., Dr TAKAFUJI H., Dr TOKUDA T., Dr MAKINO K., Saiseikai Yokohama-City Eastern Hospital, YOKOHAMA, JAPAN

POS25
Spironolactone lowers the rate of repeat revascularisation in patients presented with acute myocardial infarction: results from the Korean Acute Myocardial Infarction Registry (KAMIR) Dr SONG P.S., Inje University Haeundae Paik Hospital, BUSAN, SOUTH KOREA; Prof SONG Y.B., Samsung Medical Center, SEOUL, SOUTH KOREA; Dr KIM D.K., Prof KIM D.I., Inje University Haeundae Paik Hospital, BUSAN, SOUTH KOREA; Prof GWON H.C., Samsung Medical Center, SEOUL, SOUTH KOREA

POS34
Effects of the radial approach in patients with acute coronary syndromes with and without ST-segment elevation - Registry at one cardiovascular Centre Dr PIMENTEL MORALES G., Dr ALDUENDA BERNAL O.A., Dr ESTRADA GALLEGOS J., Dr CLAVELLINAS ROSAS J.M., Dr GONZALEZ DIAZ B., Dr MONTOYA GUERRERO S.A., Dr RAMIREZ REYES H., Dr ASTUDILLO SANDOVAL R., Dr SANTIAGO HERNANDEZ J., Dr PALOMO VILLEDA A., Dr URIBE GONZLEZ L.J., Dr NAVA PEA J.R., Dr CALDERON ABBO M., Hospital de Cardiologia, Centro Medico Nacional Siglo XXI, Ciudad de Mexico, Mexico

POS26
An unusual case of large LV myxoma extending through aortic valve presented in a young male with antero septal myocardial infarction Dr BABBURI J.R., Apollo Heart Institutes, Apollo Hospitals, HYDERABAD, INDIA

AsiaPCR/SingLIVE 2014 - Programme 39

POSTER GALLERY

POS35
Efficacy and safety of a Paclitaxel-eluting stent in patients with coronary artery disease - Registry at one cardiovascular centre, late-term outcomes Dr ESTRADA GALLEGOS J., Dr PIMENTEL MORALES G., Dr ALDUENDA BERNAL O.A., Dr GONZALEZ DIAZ B., Dr RAMIREZ REYES H., Dr MONTOYA GUERRERO S.A., Dr ASTUDILLO SANDOVAL R., Dr SANTIAGO HERNANDEZ J., Dr GONZALEZ GARCA E., Dr PALOMO VILLEDA A., Dr URIBE GONZLEZ L.J., Dr CALDERON ABBO M., Hospital de Cardiologia, Centro Medico Nacional Siglo XXI, Ciudad de Mexico, Mexico

POS44
Comparison between first and second generation drug-eluting stent implantation for unprotected left main coronary artery bifurcation lesions Dr TSUTSUMI M., Dr MURAMATSU T., Dr TSUKAHARA R., Dr ITO Y., Dr ISHIMORI H., Dr HIRANO K., Dr NAKANO M., Dr ARAKI M., Dr KATO T., Dr KOBAYASHI N., Dr TAKIMURA H., Dr SAKAMOTO Y., Dr MORI S., Dr ISHII A., Dr TAKAMA T., Dr TAKAFUJI H., Dr TOKUDA T., Dr MAKINO K., Saiseikai Yokohama-City Eastern Hospital, YOKOHAMA, JAPAN

POS36
Second and third generation drug-eluting stents in acute STEMI, long-term outcomes Dr PIMENTEL MORALES G., Dr ESTRADA GALLEGOS J., Dr ALDUENDA BERNAL O.A., Dr GONZALEZ DIAZ B., Dr MONTOYA GUERRERO S.A., Dr LOPEZ CAMPOS J.L., Dr RAMIREZ REYES H., Dr ASTUDILLO SANDOVAL R., Dr SANTIAGO HERNANDEZ J., Dr URIBE GONZLEZ L.J., Dr GONZALEZ GARCA E., Dr PALOMO VILLADA A., Dr CALDERON ABBO M., Hospital de Cardiologia, Centro Medico Nacional Siglo XXI, Ciudad de Mexico, Mexico

POS45
Characteristics of myocardial infarction with minimal STsegment elevation and their prognosis after primary PCI Dr SE YONG J., Dr MYUNG HWAN B., Dr JAE HEE K., Dr JANG HOON L., Dr DONG HEON Y., Dr HUN SIK P., Dr YONGKEUN C., Dr SHUNG CHULL C., Kyungpook National University Hospital, DAEGU, SOUTH KOREA

POS46
Feasibility of transradial coronary intervention in patients with cardiac arrest caused by acute myocardial infarction Dr MIZUGUCHI Y., Dr TAKAHASHI A., Dr YAMADA T., Dr TANIGUCHI N., Dr HATA T., Dr NAKAJIMA S., Sakurakai Takahashi Hospital, KOBE, JAPAN

POS37
Radial approach in percutaneous for coronary angiography and cardiovascular interventions: procedural aspects and longterm outcomes Dr ESTRADA GALLEGOS J., Dr PIMENTEL MORALES G., Dr ALDUENDA BERNAL O.A., Dr GONZALEZ DIAZ B., Dr MONTOYA GUERRERO S.A., Dr RAMIREZ REYES H., Dr ASTUDILLO SANDOVAL R., Dr SANTIAGO HERNANDEZ J., Dr PALOMO VILLADA A., Dr URIBE GONZLEZ L.J., Dr CALDERON ABBO M., Hospital de Cardiologia, Centro Medico Nacional Siglo XXI, Ciudad de Mexico, Mexico

POS47
A comparative study of transradial coronary angiography in octogenarians within a regional centre in Australia Mr DEVENNEY D., The Wollongong Hospital, WOLLONGONG, AUSTRALIA

POS48
In-hospital and intermediate term outcomes of cobalt chromium alloy stents in patients undergoing elective PCI Dr RAYMOND R., Ain Shams University, CAIRO, EGYPT

POS38
Clopidogrel resistance in Bangladeshi patients undergoing PCI and their relation with CYP2C19*2 Prof HAQ M.M., Dr KABIR C.M.S., Ibrahim Cardiac Hospital & Research Institute, DHAKA, BANGLADESH

POS49
Renal denervation using standard electrophysiology ablation catheter for resistant hypertension at limit-resource setting Dr TRAN H.B., Dr PHAN P.D., Dr NGUYEN Q.N., Prof PHAM H.M., Prof DO L.D., Viet Nam National Heart Institute, HANOI, VIET NAM

POS39
Stenting in diabetic patients Ms SOOMRO K., Dow University of Health Sciences, KARACHI, PAKISTAN

POS40
Groin dressing post cardiac catheterisation: traditional pressure vs. transparent film Ms ALSHUALAH R., Royal Commission Hospital, JUBAIL, SAUDI ARABIA

POS50
Immediate and short-term follow-up results of thoracic endovascular aortic repair for acute type-B aortic dissection Dr LE T.X., Dr NGUYEN Q.N., Prof PHAM H.M., Prof NGUYEN V.L., Viet Nam National Heart Institute, HANOI, VIET NAM

POS41
Triple vs. dual antiplatelet therapy after stent-based PCI for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stenting) II registry Dr SONG P.S., Inje University Haeundae Paik Hospital, BUSAN, SOUTH KOREA; Prof SONG Y.B., Samsung Medical Center, SEOUL, SOUTH KOREA; Dr KIM D.K., Inje University Haeundae Paik Hospital, BUSAN, SOUTH KOREA; Prof GWON H.C., Samsung Medical Center, SEOUL, SOUTH KOREA

POS51
Feasibility of intracoronary bone marrow derived stem cells therapy after acute myocardial infarction Dr PHAN D.T., Dr TRAN H.B., Dr DO C.T., Dr NGUYEN Q.N., Prof PHAM H.M., Prof NGUYEN V.L., Viet Nam National Heart Institute, HANOI, VIET NAM

POS52 POS42
Catheter-based renal denervation by using a standard electrophysiology catheter: primary results in Viet Nam Dr TRAN H., Viet Nam Heart Institue, HA NOI, VIET NAM Immediate and in-hospital outcome of percutaneous transvenous mitral commissurotomy with or without heparin in patients with mitral stenosis Dr RAHMAN D.M.T., National Institute of Cardiovascular Diseases, DHAKA, BANGLADESH

POS43
Impact of platelet reactivity on clopidogrel after PCI with second generation drug-eluting stent on the late lumen loss at follow-up Dr ISOMURA N., Showa University Northern Yokohama Hospital, KANAGAWA, JAPAN

POS53
In-hospital outcomes of thrombolytic-facilitated PCI in acute STEMI Dr ZYRIANOV I., Dr BESSONOV I., Prof KUZNETSOV V., Tyumen Cardiology Center, TYUMEN, RUSSIAN FEDERATION

AsiaPCR/SingLIVE 2014 - Programme 41

POSTER GALLERY

POS54
Two-year outcome of biodegradable polymer surface coatings Biolimus-eluting vs. bare metal stents in patients with acute myocardial infarction Dr HUANG W.C., Dr CHIANG C.H., Kaohsiung Veterans General Hospital, KAOHSIUNG, TAIWAN; Dr LIN T.W., Cheng Shiu University, KAOHSIUNG, TAIWAN; Mr YANG J.S., Department of Physical Therapy, Fooyin University, KAOHSIUNG, TAIWAN; Dr CHENG C.C., Dr KUO F.Y., Dr CHIOU K.R., Dr MAR G.Y., Dr LIU C.P., Kaohsiung Veterans General Hospital, KAOHSIUNG, TAIWAN

POS60
Electrocardiographic characteristics of patients presenting with left main STEMI Dr CHUA K., Dr KOH C.H., Dr YAP J., Ms CHIAM J.R., Ms SIM L.L., Dr TAN J., Dr WONG A., Prof LIM S.T., Prof KOH T.H., Dr YEO K.K., National Heart Centre Singapore, SINGAPORE, SINGAPORE

POS61
Success rates of radial procedures with or without vasodilator cocktail - Single centre experience Dr HEGDE P., The Wollongong Hospital, WOLLONGONG, AUSTRALIA

POS55
The improvement of early mobilisation in patients with acute myocardial infarction using continuous quality improvement progamme Dr HUANG W.C., Kaohsiung Veterans General Hospital, KAOHSIUNG, TAIWAN; Dr LIN T.W., Cheng Shiu University, KAOHSIUNG, TAIWAN ;Dr CHIANG C.H., Kaohsiung Veterans General Hospital, KAOHSIUNG, TAIWAN ;Mr YANG J.S., Department of Physical Therapy, Fooyin University, KAOHSIUNG, TAIWAN ;Dr CHENG C.C., Dr KUO F.Y., Dr CHIOU K.R., Dr MAR G.Y., Dr LIU C.P., Kaohsiung Veterans General Hospital, KAOHSIUNG, TAIWAN

POS62
Long-term results of PCI for severe coronary artery disease using the sirolimus-eluting stent Dr SIEGRIST P., Dr SUMITSUJI S., Dr YOKOI K., Osaka, Dr YOSHIDA M., Dr OKAYAMA K., Dr IDE S., Dr MIZOTE I., Dr KUMADA M., Dr TACHIBANA K., Prof NANTO S., Osaka University Graduate School of Medicine, SUITA, JAPAN

POS63
Out of hospital cardiac arrest (OHCA) correlation between ST elevation on electrocardiogram and benefits from emergency coronary angiography -Single centre experience Dr HEGDE P., The Wollongong Hospital, WOLLONGONG, AUSTRALIA

POS56
Clinical, procedural characteristics and outcomes in left main STEMI - A single-centre retrospective review on in-hospital mortality Dr CHUA K., Dr YAP J., Dr KOH C.H., Ms CHIAM J.R., Ms SIM L.L., Dr TAN J., Dr WONG A., Prof LIM S.T., Prof KOH T.H., Dr YEO K.K., National Heart Centre Singapore, SINGAPORE, SINGAPORE

POS64
Safety and clinical performance of the drug-eluting Orsiro stent in the treatment of patients with single de novo coronary artery lesions in an Indian population (BIOFLOW-India) Dr CHANDRA P., Medanta Medicity Hospital, HARYANA, INDIA; Dr MULLASARI A., Madras Medical Mission, CHENNAI, INDIA; Dr KUMAR V., Fortis Escorts Heart Institute and Research Centre, NEW DELHI, INDIA; Dr KAUL U., Max Super Speciality Hospital, NEW DELHI, INDIA; Dr WAKSMAN R., MedStar Heart Institute, WASHINGTON DC, UNITED STATES

POS57
The clinical outcome of 50% reduction of low density lipoprotein-cholesterol (LDL-C) in patients with acute myocardial infarction: a propensity score matched analysis Prof SUH S.Y., Prof AHN T., Gachon University Gil Hospital, INCHEON, SOUTH KOREA; Prof AHN Y., Prof JEONG M.H., Chonnam National University Hospital, KWANGJU, SOUTH KOREA; Prof LEE K., Prof KANG W.C., Prof HAN S.H., Prof SHIN E.K., Dr OH P.C., Dr SEO J., Gachon University Gil Hospital, INCHEON, SOUTH KOREA

POS65
Implementation of a regional network to reduce reperfusion times in the management of patients with STEMI undergoing primary PCI intervention: the Lausanne experience Dr IGLESIAS J.F., Dr TRANA C., Dr TAPPONNIER M., Dr ROGUELOV C., Dr LOCCA D., Dr MULLER O., Prof VOGT P., Prof EECKHOUT E., Lausanne University Hospital, LAUSANNE, SWITZERLAND

POS58
Clinical outcomes of drug-eluting balloon in treatment of coronary in-stent restenosis compared to plain old balloon angioplasty Prof SUH S.Y., Prof KANG W.C., Dr OH P.C., Dr SEO J., Prof LEE K., Prof HAN S.H., Prof AHN T., Gachon University Gil Hospital, INCHEON, SOUTH KOREA

POS66
Does the existence of primer coating on Biolimus-eluting stents with abluminal biodegradable polymer influence clinical outcomes? Insights from the large all-comers eBioMatrix registry Dr MENOWN I., Craigavon Centre, CRAIGAVON, UNITED KINGDOM

POS59
Trans-esophageal echocardiographic follow-up of patients with mitral stenosis before and after successful percutaneous transvenous mitral commissurotomy Dr RAHMAN D.M.T., National Institute of Cardiovascular Diseases, DHAKA, BANGLADESH

AsiaPCR/SingLIVE 2014 - Programme 43

Experience AsiaPCR/SingLIVE the smart way


with the Course in the palm of your hand
Download the PCR smartphone application!
Available for iPhone, Android, Blackberry and Windows Phone

INDUSTRYSUPPORTED PROGRAMME: A WORD FROM OUR PARTNERS

Abbott Vascular invites you to join the luncheon symposium on DES safety and BVS real world practice Join us in room 2, Suntec International Convention & Exhibition Centre on Thursday 16th January, 2014. Biodegradable Polymer Offers No Extra Benet in DES will be presented by Jack Tan, National Heart Centre, Singapore

BVS Case Based Discussion in Acute Myocardial Infarction will be presented by Adrian Low, National University Hospital, Singapore BVS Case Based Discussion in Bifurcation will be presented by Robert J. Van Geuns, Erasmus Medical Center, The Netherlands Join us!

Thursday 16th January, 12:35-13:55 ROOM 2

Biosensors International is a medical device company specialising in coronary and peripheral arterial intervention. Our product portfolio includes a wide range of stents and balloons and, more recently, we are also able to offer a functional vascular imaging system to improve patient diagnostics. Over the last few years, we have grown to become the worlds fourth-largest supplier of coronary stents. Our global sales, marketing and clinical headquarters are based in Morges, Switzerland, and our financial, R&D and manufacturing centre is located in Singapore. Biosensors International stands for excellence through innovation to achieve the best possible outcomes for patients. Examples of our innovative programme include the development of Biolimus A9 (BA9), our proprietary anti-restenotic drug, specifically designed for use on coronary stents. Our stent range

includes biodegradable polymer products and, more recently, a completely polymer-free drug coated stent, both with Biolimus A9 (BA9) as the active pharmaco-therapeutic agent. The Biosensors International symposium is highly relevant to current coronary interventional practice and should be of great interest to all clinicians practicing in this field. Topics include a discussion of the data supporting the long-term outcomes of patients treated with biodegradable polymer stents including important results from trials focussing specifically on patients from Asia. There will also be a discussion on the management of intervention for AMI patients with compelling evidence that the choice of DES product may influence patient outcome. Other topics focus on the perennial interventional conundrum as to how best to

treat bifurcation lesions and the role of tailored bifurcation devices to improve outcomes in this high risk patient group. Finally, the symposium will include a discussion on the management of dual anti-platelet therapy (DAPT) in patients with a high bleeding risk and the contribution that device technology may offer to these patients. This is a key patient group, rarely included in clinical trials but frequently appearing in the catheter laboratory. Biosensors International extends a warm welcome to all delegates at AsiaPCR 2014 and looks forward to seeing you at our symposium and on our booth.

Thursday 16th January, 18:00-19:20 MAIN ARENA

Bioabsorbable polymers and DEBs: Is the next step a fully absorbable magnesium scaold? Since the invention of metallic stents for the treatment of coronary occlusions, the technology of PCI has pursued improvements. Modern stents have undergone generations of advancements and now there seems to be a trend to evolve the treatment away from a permanent implant. In this lunch time session (Friday, January 17, 12:35-13:55, Room 2), sponsored by BIOTRONIK AG, we will take a look at a new drug-eluting stent with modern stent design and bioabsorbable polymer: the Orisro Hybrid Stent. AsiaPCR course co-director, Eric Eeckhout from Centre Hospitalier Universitaire Vaudois, Switzerland, will be sharing specics of the stent design, as well

as the 1-year results from the BIOFLOW-II study that compares the Orsiro to the Xience Prime. Prof. Uperdra Kaul from Fortis Escorts Heart Institute in India will immediately follow this talk with results from the all-comers registry, BIOFLOW-III, as well as the BIOFLOW-INDIA study that will look at highly complex patients from India. In cases where stenting is not optimal, another absorbable technology has been the drug-eluting balloon. Dr. Jim Man Hong form Grantham Hospital, Hong Kong will be sharing his data from his SARPEDON study in bifurcations lesions with the Pantera Lux Paclitaxel Eluting Balloon. Next, we will be hearing from course co-director Prof. Soo-Teik Lim from National Heart Center, Singapore, on an absorbable metallic scaold and his early experience in the BIOSOLVE-II study to investigate the

latest generation of this device. This session will close up with a panel discussion on the evolution from bioabsorbable polymer to a fully magnesium scaold. This session is aimed at informing the attendee of new technologies from BIOTRONIK that are aimed at minimizing the implant that is left behind following PCI. Attend this session if you are looking for modern tools with clinical evidence and join in the discussion with key opinion leaders on these devices.

Friday 17th January, 12:35-13:55 ROOM 2

AsiaPCR/SingLIVE 2014 - Programme 45

INDUSTRYSUPPORTED PROGRAMME: A WORD FROM OUR PARTNERS

Advancing Cardiology with Innovative Technologies and Clinical Research Boston Scientic is committed to Advancing Cardiology, delivering meaningful innovation that improves the quality and efficiency of care. Therefore, in Boston Scientics lunch symposium on 16th Jan 2014, this session chair by Prof Koh Tian Hai and Dr Jean Fajadet , will comprise the science advancement and evolution of stent technology, the treatment of resistant hypertension and the oering of new therapies to patient with severe aortic valve disease. For more than a decade, Boston Scientic has worked with physicians to evolve stent design, introducing six new platforms that have transformed the practice of interventional cardiology.

We have received FDA approval and launched the next evolution in stent technology with the Promus PREMIERTM PtCr Stent System, the rst stent with a customized architecture, and the SYNERGYTM Stent System, which features synchronous drug and bioabsorbable polymer technology. Today, Boston Scientific is working with physicians to transform the treatment of resistant hypertension, oering hope to the millions of patients worldwide with blood pressure that remains above goal, despite medical treatment. Designed with familiar over-the-wire balloon technology, the VessixTM Renal Denervation System delivers localized bipolar energy in 30 second treatment time. The Vessix Global Clinical Program continues to

produce robust patient-focused data utilizing the VessixTM System. Last but not least, we would like to take this session to share a brief overview of our recent CE Mark approved LotusTM Aortic Valve, which was designed with physician input for precise, predictable placement and a unique Adaptive Seal designed to reduce paravalvular leakage for improved patient outcome. We look forward to continued partnership to drive these promising therapies for patients. Together were advancing cardiology.

Thursday 16th January, 12:35-13:55 MAIN ARENA

MAQUET invites you to join luncheon symposium on Tailoring haemodynamic support to the specic needs of the unstable patient undergoing PCI. Join us in room 3, Suntec International Convention & Exhibition Centre, on Thursday 16th January, 2014.

Percutaneous extra-corporeal membrane oxygenation vs. percutaneous ventricular assist or intra-aortic balloon pump therapy: which device and when? will be presented by Chandra Praveen, Medanta Medicity Hospital, India. IABP- SHOCK II Trial: what does this mean for your clinical practice? will be presented

by Rathnavel Sivakumar, Meenakshi Mission Hospital & research Centre, India. Join us!

Thursday 16th January, 12:35-13:55 ROOM 3

SYMPOSIUM: COMBO dual therapy stent: an eective stent option On Friday January 17th, Prof Harry Suryapranata from the (Radboud University Medical Center, The Netherlands) will chair the OrbusNeich lunch symposium entitled COMBO dual therapy stent: an effective stent option. Panellists include Dr Tresukosol Damras (Siriraj Hospital, Thailand) and Dr Teguh Santoso (University of Indonesia Medical School & Medistra Hospital) Prof Stephen W.L. Lee, Queen Marys Hospital, Hong Kong will present clinical data from the 24 month EGO COMBO study.

This study was the rst of its kind to assess the healing prole of a drug eluting stent by longitudinal sequential optical coherence tomography (OCT) and uniquely showed an improvement in outcomes from 9 to 24 months in terms of regression in neointimal thickness (NIT), neointimal volume (NIV) as well as decreased in-stent % plaque volume without any denite or probable late stent thrombosis. Prof Giuseppe de Luca (Eastern Piedmont University of Novara, Italy) will provide a recap on the current AHA/ACC DAPT guidelines for acute coronary syndrome (ACS) patients and the available choices in antiplatelet agents, as well as share with us clinical

evidence of short term vs long term DAPT regimes and possible associated side eects and leading to introduction of the REDUCE Trial, to evaluate the safety of the COMBO stent with reduced DAPT in ACS patients. Dr Aaron Wong from the Singapore National Heart Centre will be presenting the 6m and 12m clinical results of his single centre study as well as update us with the 24m REMEDEE clinical data.

Friday 17th January, 12:35-13:55 ROOM 3

Tools and Techniques (TNT) with Live @ Main Arena This Industry-supported session with LIVE demonstrations theme will be: Towards a better patient care: beyond the limitation of transradial intervention ~ World renown Interventional Cardiologists, Dr. Marie Claude Morice (France) and Dr. Shigeru Saito (Japan) will be taking chair. The live case from National Heart Centre Singapore operated by Dr. Rosil Mohd Ali (Malaysia), will be conducting a trans-radial case. Session will be highlighting use of OFDI, and
AsiaPCR/SingLIVE 2014 - Programme

will have Dr. Takashi Akasaka (Japan) as live case commentator. The session will be followed by 3 lectures focusing on transradial intervention. Lecture 1: Fuminobu Yoshimachi (Japan) The evolution of less invasive PCI. Lecture 2: Paul Ong (Singapore) - Doing our best to treat AMI: doing it transradially. Lecture 3: Jean Fajadet (France) - New transradial interventional treatment: transradial renal sympathetic denervation. This session is open to all participants who wishes to learn the following: To understand how to overcome the

challenges of TRI for complex case using imaging technique. To discuss the niggling issues of Trans-Radial approach and how Slender TRI concept can help tackle them. To learn about less invasive renal nerve ablation procedure from radial artery, its benet and challenges.

Friday 17th January, 12:35-15:50 MAIN ARENA

47

FLOOR PLAN

MAIN ARENA

ROOM 2

ROOM 3

INTERACTIVE CASE CORNER

TRAINING VILLAGE

Boston Scientic

Medtronic International

4 CityNeon Desk 18 24 25 26 27 30 31
Registration Area
Poster Gallery

BUFFET
7 8 10 19

Speaker Service Centre & Guest Lounge

ROOM 4
Lounge Area
Congress bag pick-up

32 28 34

17 14

21 23 38

Exhibitor Support Centre

37 36 35

Cloakroom

ENTRANCE

1 2 3 4 6 7 8

Maquet South East Asia Pte Ltd BIOTRONIK ALVIMEDICA Medical Technologies Covidien Biosensors International Technologies Pte Ltd Hexacath SAS Abbott Vascular

23 BALTON 24 Kaneka Medix Corporation 25 St Jude Medical 26 Goodman Co., Ltd 27 ASAHI INTECC CO., LTD 28 STENTYS 30 TRANSMEDIC 31 Edwards Lifesciences 32 MINVASYS 34 B.BRAUN SINGAPORE PTE LTD 35 CARDIOVASCULAR SUMMIT-TCTAP 2014 36 INNOHEART 37 ResearchBooks Asia Pte Ltd 38 P.G BOOKS (PTE) LTD

10 ORBUSNEICH 14 NHCS 17 Medtronic International Ltd 18 Boston Scientic Asia Pacic Pte Ltd 19 TERUMO Asia Holdings PTE.LTD. 21 CENTER FOR EUROPEAN RESEARCH IN CARDIOVASCULAR MEDICINE

AsiaPCR/SingLIVE 2014 - Programme 48

EXHIBIT GUIDE

Exhibit guide
Abbott Vascular
Stand n 8

BALTON

Stand n 23

Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people. Abbott Vascular is the worlds leader in drug eluting stents. Abbott Vascular has an industry-leading pipeline and a comprehensive portfolio of market-leading products for cardiac and vascular care, including products for coronary artery disease, vessel closure, endovascular disease and structural heart disease.

ALVIMEDICA Medical Technologies

Stand n 3

BALTON Ltd. is the manufacturer of medical equipments since 1980.The product range is divided into six groups: cardiology with radiology, anesthesiology, surgery, dialysis, urology, gynecology. One of the most important achievements of the company is production of stents, including DES with biodegradable polymer. During Asian PCR 2013 we have an honor to present our brand new dedicated bifurcation stent- BIOSS LIM- Sirolimus eluting version, and also new low profile Cobalt-Chromium Sirolimus Eluting Coronary Stent- Alex. BALTON cooperates with many scientific centers, clinics and companies in Poland and Europe. Our motto is flexibility, innovation, wide range of products, consumer oriented with competitive pricing. BALTON Ltd. 294 Modlinska str., 03-152 Warsaw, POLAND Phone: +48 597 44 00 - Fax: +48 597 44 44 balton@balton.pl www.balton.pl Contact: Mariusz Sarna Export Manager export.manager@balton.pl

Alvimedica is a young, agile company devoted to developing minimally-invasive medical technologies for medical professionals looking for the next level of innovation in the operating room. Our salesforce and R&D departments work so closely with physicians on product improvement that co-creation would be a more fitting term. Alvimedica manufactures products using cutting-edge design and technologies to deliver world-class quality products and services. The growing and innovative product portfolio offers both peripheral vascular and interventional cardiology, consisting of world-class guidewires, guiding, diagnostic and balloon catheters and bare metal as well as drug eluting stents. Our commitment to improving surgical procedures through innovative products is driven by our sincere care for patients quality of life and our goal to positively impact clinical outcomes. As our motto says: we want to help physicians bring their patients Back to Life! as soon as possible (and based on safe medical practices). www.alvimedica.com

Biosensors International Technologies Pte Ltd

Stand n 6

ASAHI INTECC CO., LTD

Stand n 27

ASAHI INTECC CO., LTD. is a Japan-based company principally engaged in the development, manufacture, and sale of medical devices. The company offers interventional cardiology products used in the treatment of coronary artery disease: percutaneous transluminal coronary angioplasty (PTCA) guide wires, micro catheters, guiding catheters and dilatation catheters. ASAHI INTECC distributes its products across US, Europe and Asia Pacific.

Biosensors develops, manufactures and markets pioneering interventional cardiology devices. Our core product line, the BioMatrix DES family, couples an abluminal biodegradable polymer with our own limus drug, Biolimus A9 (BA9). BioMatrix NeoFlex , the latest addition to this family, combines Gold Standard clinical results with our most deliverable stent system ever. BioFreedom, the first polymer-free BA9-coated stent, is now being launched in selected markets. Additional products include Axxess, a dedicated bifurcation DES, a new range of drug-eluting balloons, and the Spectrum Dynamics diagnostic imaging system.

BIOTRONIK

Stand n 2

B.BRAUN SINGAPORE PTE LTD

Stand n 34

B. Braun Sharing Expertise. The B. Braun Group stands for competence in healthcare. Since 1839, from its headquarters in Germany, B. Braun has developed into a worldwide group of companies and a leading supplier for the healthcare market. In close partnership with its customers, B. Braun develops the best solution for patients, thereby making an important contribution to medical advances. Today it operates in more than 50 countries with 47,000 employees worldwide. Quality in Vascular Systems For successful and efficient treatment of even the most difficult cardiovascular cases, B. Braun offers comprehensive system solutions and customer-specific sets. With an extensive and innovative portfolio of products and services, B. Braun is a competent partner for doctors in cardiology and vascular surgery across the globe, offering interventional and surgical product systems for the diagnosis and treatment of cardiovascular diseases. B. Braun Singapore Pte Ltd 600 North Bridge Road, #15-05 Parkview Square, Singapore 188778 Phone: (+65) 6213 0933 - Fax : (+65) 6213 0930 www.bbraun.com.sg

BIOTRONIK founded in 1963 is a world leading manufacturer of cardio- and endovascular medical technology. Innovations like BIOTRONIK Home Monitoring, the worlds first 4F compatible 200mm peripheral stent, and Orsiro, the industrys first hybrid drug-eluting stent, have improved the health and well-being of millions of patients worldwide. BIOTRONIK AG Ackerstrasse 6, 8180 Blach, Switzerland Phone: 00 41 44 864 51 11 - Fax: 00 41 44 864 51 30 info.vi@biotronik.com www.biotronik.com

Boston Scientific Asia Pacific Pte Ltd

Stand n 18

Boston Scientific (NYSE: BSX) transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. > One of the worlds largest medical device companies > More than 13,000 products in our portfolio > 15,000+ patents issued; ~8,500 applications pending worldwide (11) > ~$1 billion invested annually in R&D > ~24,000 employees > Sales forces in more than 40 countries

AsiaPCR/SingLIVE 2014 - Programme 49

EXHIBIT GUIDE

Exhibit guide
Locations > Global Corporate Headquarters: Natick, MA > Regional Headquarters: Paris and Singapore > Major Technology Centers: Minnesota, California, Ireland and Costa Rica > 12 manufacturing facilities worldwide www.bostonscientific.com

Edwards Lifesciences

Stand n 31

CARDIOVASCULAR SUMMIT-TCTAP 2014

Stand n 35

TCTAP2014 will be held from April 22 to 25 in Seoul, Korea sponsored by CVRF. CardioVascular Research Foundation (CVRF) is a non-profit organization dedicated to improving the lives of patients with cardiovascular disease. It organizes world-class educational meetings including CARDIOVASCULAR SUMMITTCTAP (April 22-25, 2014), TAVI SUMMIT (August 8-9, 2014), IMAGING&PHYSIOLOGY SUMMIT (December 5-6, 2014). It operates training program every monthly and conduct a large number of researches through Data Coordinating Center, QCA and IVUS Core Laboratories. For more information, please visit our websites. www.summit-tctap.com www.imaging-physiology.com www.taviconference.com www.cvrf.org Contact: Miju Hwang / mijuhwang@summitmd.com Karen Kim / karen@summitmd.com

Heart Valve Therapy Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Since developing the first heart valve in 1958, we have continued to meaningfully advance heart valve therapy which includes tissue replacement heart valves and valve repair products. We also lead the development of new investigative technologies designed for the non-surgical replacement of heart valves. We believe transcatheter valves hold great promise for patients considered high-risk for conventional valve replacement .Our Edwards SAPIEN transcatheter heart valve has been commercially available in Europe since 2007 and is being studied in the U.S. PARTNER Trial, the worlds first randomized clinical trial of a transcatheter heart valve. Our Edwards SAPIEN XT valve, the second commercially available transcatheter valve in the Edwards SAPIEN product portfolio, is currently being studied in Japans first clinical trial of a transcatheter valve.

Goodman Co., Ltd

Stand n 26

CENTER FOR EUROPEAN RESEARCH IN CARDIOVASCULAR MEDICINE

Stand n 21

The CERC founded in 2008 is a unique Contract Research Organization conceived and founded by interventional cardiologists with wide experience in clinical research. The CERC was created with the aim of establishing a reputable high-quality dedicated CRO in Europe. Its objectives are to underpin European clinical trials and academic leadership, act as a global CRO and support young scientific leaders. The prestigious members of the CERCs Medical Advisory Council provide unparalleled guidance and expert support in a broad range of clinical trials dedicated to the assessment of interventional coronary and peripheral revascularization, structural and valvular heart disease treatments and adjunctive pharmacology. The CERC has an excellent track record in regulatory guidance, trial design, strategic planning, global study management and monitoring, biometry, CEC/DSMB coordination, AE and SAE management, core-lab activities. The company is ISO 9001:2008 certified. Contact: Abderrahim Kadri (Business Development) kadri@cerc-europe.org Phone :+33675655905

In the 1970s, Goodman, quick to comprehend the future prospects of emerging medical technology and devices in the field of interventional cardiology, commenced importation and development of diagnostic and therapeutic equipment devices and software. Through the knowledge and experience gained in domestic distribution, a strong emphasis was placed on ensuring a transition from primary importer/distributor, to one of manufacturer/distributor that uniquely addressed the needs of the interventional cardiologist in order to best treat the patient. The medical field is one of rapid advance, and requires diligence in accurate response to progress. Goodmans employees are vigilant in ensuring the products provided remains at the forefront of innovation and design. Through providing leading edge medical technology, Goodman is proud to contribute to the betterment of society.

Hexacath SAS

Stand n 7

HEXACATH is a company developing, manufacturing and selling innovative cardiovascular products. Set up in 1994, HEXACATH has expanded its sales network in as many as 40 countries including 15 direct subsidiaries. Its unique technology based on titanium-nitride-oxide coating brings an alternative called BAS (Bio Active Stent) to the current established stent technologies which are BMS and DES. At AsiaPCR/SingLIVE, HEXACATH will present its wide range of products: the newly introduced TITAN OPTIMAX, combining Titanium-Nitride-Oxide with an outstanding stent platform providing unmatched stent profile and deliverability; HELIOS balloon expandable renal stent; HELIFLEX self-expanding stent for SFA; PCTA balloons Mistral SC & NC; ZONDA a new Paclitaxel eluting balloon and RECOVER a new thrombo-aspiration catheter. Hexacath 4 Passage St Antoine, 92508 Rueil Malmaison Yannick Giraud-Sauveur Sales & Marketing Director Hexacath ygiraud@hexacath.com Phone : (33) 1 41 39 01 90 Customer service : commercial@hexacath.com Phone : (33) 1 41 39 01 92

COVIDIEN

Stand n 4

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading products in medical devices and supplies. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.

AsiaPCR/SingLIVE 2014 - Programme 50

EXHIBIT GUIDE

INNOHEART

Stand n 36

MINVASYS

Stand n 32

Innoheart is a GLP-certified, pre-clinical CRO (Contract Research Organization) in Singapore, providing invivo studies for medical device evaluation e.g. cardiac, surgical, orthopaedic, dental, implants, stem-cell scaffolds, etc. We are also a training facility for physicians and med-tech professionals for Coronary Intervention/Ablation, Heart-Lung Bypass, Laparoscopic/ Endoscopic procedure training, etc. Our facility is well-equipped with an Angiosuite, Operating Theatres and a Histology Lab. We have a professionally-trained team, comprising of highly-qualified and experienced clinicians, scientist, veterinarians, project/lab officers to plan, manage and execute research studies with a rapid turnaround. To offer our clients complete turnkey solutions for their research needs, we also develop disease models e.g. stroke, myocardial infarction, aneurysm, burn injury, bone defect, structural heart defect models and provide histology services (e.g. H&E, Massons Trichrome staining, SEM). Innoheart Pte Ltd Pan Yumei ym_pan@innoheart.com Phone: +65 97363220

Kaneka Medix Corporation

Stand n 24

MINVASYS is an international privately held company based in the Paris area, France. Based on its strong experience, MINVASYS is a reference for bifurcation treatment bringing to the market innovative systems: Nile PAX and Nile Croco,dedicated stents and delivery devices for coronary bifurcation. MINVASYS has successfully launched its PTCA Drug Eluting Balloon, Danubio. MINVASYS offers a wide range of performing medical devices, including PTCA balloons Yangtze , cobalt chromium stents Amazonia Croco, polymer free Paclitaxel stents, Amazonia PAX and Nile PAX and a thrombo-aspiration catheter, Stemicath. MINVASYS is also the manufacturer of the unique and original vascular access system SuperKetch / SpeedKetch. MINVASYS operates internationally through a distributor network. HEADQUARTERS MINVASYS 7, rue du Foss Blanc, 92230 Gennevilliers, France Phone : +33 (0) 1 47 90 70 30 www.minvasys.com info@minvasys.com

Kaneka Medix Corporation is highly dedicated to developing and providing high quality, innovative products in the field of catheter therapeutics. Our interventional business portfolio covers widely in Coronary, Peripheral and Neurovascular lesions with numbers of leading and doctororiented niche special products; Thrombus Aspiration Catheter Thrombuster, PTCA Balloon Catheter Ikazuchi Rev, OTTIMO-EX, Fortis II, GW Support Catheter Crusade, CTO Penetration Catheter Sortana F/X, PTA Catheter, Embolic Coil, etc. 2-5-8, Higashi-Shinagawa Shinagawa-Ku, Tokyo 140-0002, JAPAN Phone: +81 3 5461 3080 - Fax: +81 3 5461 3081 www.kaneka-med.jp/english

NHCS

Stand n 14

As a 185-bed national centre for cardiovascular medicine in Singapore, the National Heart Centre Singapore (NHCS) provides one stop comprehensive preventive, diagnostic, therapeutic and rehabilitative cardiac services. We are dedicated to improving patient lives by teaching the next generation, providing clinical care and conducting research. Patients can be assured of safety and quality care at NHCS as the centre has been accredited by the Joint Commission International (JCI) since 2005. JCI is a standard-setting and accrediting body for healthcare institutions.

Maquet South East Asia Pte Ltd

Stand n 1

ORBUSNEICH

Stand n 10

MAQUET, a trusted partner for hospitals and physicians for over 175 years, is the global leader in providing medical systems that meet the needs of the most medically challenging patients, while exceeding the expectations of the hospital teams that care for them. MAQUET designs, develops and distributes innovative therapy solutions and infrastructure capabilities for high-acuity areas within the hospital including the operating room (OR), hybrid OR/cath lab and intensive care unit (ICU) as well as intra and inter hospital patient transport. Maquet Asia Pacific 20 , Bendemeer Road, Cyberhub Building, Singapore Phone : +6598387192

Medtronic International Ltd

Stand n 17

Medtronic (www.medtronic.eu) is the global leader in medical technology, offering an unprecedented breadth and depth of innovative products, therapies, and services to fulfill our Mission of alleviating pain, restoring health, and extending life. In the past year, more than 9 million people worldwide relied on our therapies, which treat many conditions including cardiac and vascular diseases, diabetes, and neurological and spinal conditions. With a global reach that extends to more than 140 countries, we have a deep understanding of many universal healthcare challenges. We are using our experience, extensive partnerships, and the passion of more than 46,000 employees to help transform healthcare worldwide by improving outcomes, expanding access, and enhancing value. Every 3 seconds, a persons life is improved by a Medtronic Product or Therapy. In FY2013, Medtronic helped improve the lives of more than 9 million people around the world.
AsiaPCR/SingLIVE 2014 - Programme

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the worlds first dual therapy stent, and the worlds first pro-healing stent, the Genous Stent. The COMBO Dual Therapy Stent accelerates endothelial coverage and controls neo-intimal proliferation through the combination of the Genous EPC capture technology with an abluminal sirolimus drug elution. Other products include stents and balloons marketed under the names of Azule, Scoreflex, Sapphire, Sapphire II and Sapphire NC. OrbusNeich is headquartered in Hong Kong and has manufacturing facilities in Hoevelaken, The Netherlands and Shenzhen, China. R&D Head quarter is in Fort Lauderdale, Fla. . OrbusNeich supplies medical devices to interventional cardiologists in more than 60 countries. For more information, visit www.OrbusNeich.com.

P.G BOOKS (PTE) LTD

Stand n 38

PG Books Pte Ltd incorporated in 1974, showcases the widest range of medical and paramedical books. Visitors to our shop, located in Orchard Road, will find the latest and current editions of medical titles covering the various disciplines. Our website is currently under construction. Orders can be placed through our email contact at sales@pgbooks.com or admin@pgbooks.com. Delivery can be arranged for overseas orders as well.

51

EXHIBIT GUIDE

Exhibit guide
Besides retail, we also supply books to various medical institutions, hospitals and pharmaceutical companies in the region with customers from Malaysia, Indonesia, Thailand, Myanmar, Philippines, Australia and as far as Africa and Russia. We are also active in medical congresses as an exhibitor. PG Books Pte Ltd 402 Orchard Road #05-21 Delfi Orchard Singapore 239976 Phone: (65) 6235 2682 Fax: (65) 6733 4854 Mobile: (65) 9155 1184 sales@pgbooks.com

STENTYS

Stand n 28

ResearchBooks Asia Pte Ltd

Stand n 37

ResearchBooks Asia is Singapores largest Scientific and Medical bookstore. We stock over 10,000 professional scientific and medical reference books in very specialised subjects. Corporate and special orders are welcome we are your best source of specialty books and resources. Email us at info@ResearchBooksAsia.com.sg or visit us at Square2 store today! We are conveniently located directly above Novena MRT station, just across from Tan Tock Seng Hospital. 10 Sinaran Drive, #03-22 Square 2 Shopping Centre, Singapore 307506 Contact: Diane Wong Phone: +65 6252 5575 - Fax : +65 6252 5235 Sales@ResearchBooksAsia.com.sg www.ResearchBooksAsia.com.sg

STENTYS is developing and commercializing innovative solutions for the treatment of patients with acute myocardial infarction (AMI, or heart attack) and complex coronary artery disease. The STENTYS Self-Apposing Stent addresses the stent-sizing dilemma that cardiologists are confronted with when treating heart attack patients or patients with atypical artery anatomy. Its flexible, self-expanding design takes the shape of the patients unique vessel anatomy and apposes to the irregular contours of a blood vessel, even as the vessel dilates and the initial clot dissolves after an AMI. It reduces the risk of malapposition and complications associated with conventional stents in this setting. In the APPOSITION III clinical trial, STENTYS stents demonstrated a very low one-year mortality rate among 1,000 high-risk AMI patients when compared to recent studies with conventional stents. STENTYS 31 Rue Saint-Augustin, 75002 Paris, France Phone : 0033 144 539 942 info@stentys.com

TERUMO Asia Holdings Pte Ltd

Stand n 19

St. Jude Medical

Stand n 25

St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the worlds most expensive, epidemic diseases. We do this by developing cost-effective medical technologies that save and improve lives. We provide technologies that are of the highest quality, which is something we take very seriously because we know patients around the world rely on our technologies. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, remote monitoring systems, cardiac mapping and visualization systems, catheter-based ablation devices, vascular closure devices, structural heart products, spinal cord stimulation, peripheral nerve stimulation and deep brain stimulation devices. St. Jude Medical (S) Pte Ltd 438B Alexandra Road Alexndra Technopark #06-03 Singapore 119968 Jasmine Loke Sales Manager Vascular Division Singapore, Viet Nam and Philippines DID +65 6643 2812 Phone: +65 6643 2800 Fax +65 6377 0025 Mobile +65 9668 0822 jloke@sjm.com

Founded in 1921 by Dr Shibasaburo Kitasato, father of modern Japanese medicine, Terumo has developed into a brand synonymous with the best in medical technology. Terumo provides world-class medical devices for use in cardiothoracic surgery, interventional procedures and blood transfusion; it also manufactures an array of syringe and hypodermic needle products for medical use. The Interventional Systems division develops quality devices and solutions for coronary, vascular and other interventional procedures, with strong focus on Trans-radial Intervention, Complex Coronary Intervention and Peripheral Intervention. With the introduction of the Optical Frequency Domain Imaging system for coronary imaging, Terumo has strengthened its position as the premier solution provider in interventional therapy. Adhering to the corporate goal of Contributing to Society Through Healthcare, Terumo continues to develop the most innovative and advance products that the healthcare community can rely on.

TRANSMEDIC

Stand n 30

Transmedic started in 1980 as an equipment distributor to cater to the medical needs of an increasingly affluent Asia. Today, it is a leading speciality partner of healthcare institutions and professionals, including bringing patients through medical tourism. Manufacturers trust us to promote and implement their latest technologies and remedies whereas customers see us as a facilitator of medical advances. Transmedic aspires to play a key role in the Cardiac Specialty representing Thoratec, Heartmate II (Left Ventricular Assist Device), Stereotaxis Magnetic Navigation, Volcano IVUS, Bayer Healthcare: Angiojet Thrombectomy Device . As we are the direct office distributor for niche products, we strive to be the hub for medical speciality products focusing on new technology & treatments in ASEAN & HK Region.

AsiaPCR/SingLIVE 20142014 - Programme 53

GENERAL INFORMATION

General information
Access
Please refer to the Suntec website to learn more on how to get to the Convention Centre: http://www.suntecsingapore.com/contactsuntec/getting-here

Badge
Registration badges must be worn at all times. Access to the Course will not be permitted without a valid and visible badge. Badges are personal.

Bag pick-up
Located in the Exhibition hall.

Friday 17th:.......................................................10:30 and 16:00 Saturday 18th: ........................................................................ 10:30 Lunch Buet: Thursday 16th: ....................................................................... 12:00 Friday 17th:............................................................................... 12:00 Saturday 18th: ........................................................................ 11:55 On Thursday and Friday lunch Bento boxes and meal boxes served outside the session rooms at 12:30. Dinner: Will be served during Industry symposia on Thursday 16th in front of the Main Arena and Room 2 at 18:00.

Certicate of attendance
You will be asked to answer the onsite survey to get your certicate of attendance. The certicate will be delivered at the registration desk from 25th January.

Free
Your badge includes access to all scientific sessions and the Exhibition hall, PLUS lunches and coee breaks.

Exhibition area Thursday 16th January ......................................7:30 - 19:40 Friday 17th January ..............................................7:00 - 18:00 Saturday 18th January ........................................ 7:00 -14:00 Onsite registration Wednesday 15th January................................9:00 - 18:00 Thursday 16th January ......................................7:30 - 19:40 Friday 17th January ..............................................7:00 - 18:00 Saturday 18th January ........................................ 7:00 -12:00 Speaker Service Centre Wednesday 15th January.............................16:00 - 18:00 Thursday 16th January ......................................7:30 - 19:40 Friday 17th January ..............................................7:00 - 18:00 Saturday 18th January ........................................ 7:00 -12:00

Photography
Photography and lming are strictly prohibited.

Hotels
For all your requests regarding your hotel booking, please contact: The Meeting Lab Pte Ltd 695e East Coast Road - Singapore 459059 Tel : 00 65 63464402 Felicia Teng - feliciateng@themeetinglab.com Sarah Ten - sarahten@themeetinglab.com Leonard Sng - leonardsng@themeetinglab.com

Cloakroom
Located near the Main entrance. Leave your luggage free of charge. Open during registration hours.

Posters area
Over 66 abstracts have been selected from the Call for submissions as posters. Find the list from page 27.

Convention center
Suntec Singapore International Convention & Exhibition Centre 1 Raes Boulevard - Suntec City Singapore 039593

Prayer rooms
Available for men and women, it is located on Level 3 of the Suntec Singapore, rooms 300 and 301.

Interactive Case Corner


Selected Clinical cases from the Call for submissions will be discussed. See the programme yer for the corresponding times of these sessions.

Exhibitors
See the exhibition map. Information also available with the smartphone application.

Session room capacity


Each session room has a limited capacity and we are unable to reserve seats, therefore once the room is full, for security reasons we will be unable to permit further access.

Internet
Free wi is available at level 3 and4. Select the network FREE_WIFI@SuntecSingapore. No password required. Please note that access may be limited at peak periods.

Exhibitor Support Centre


For exhibitors only. Information oce located in the exhibition hall near the Speaker Service Centre.

Smartphones
An application dedicated to the Course is available for Android, iPhone and Blackberry. Includes: breaking news, scientic programme, exhibitors, Faculty and more.

Food & beverage


Pre Course only: Wednesday 15th Coee breaks: ................................................9:00 and 15:40 Lunch boxes:......................................................................... 12:20 Coee breaks and meal boxes available near the entrance of the room. Course: Tea and coee served in the Exhibition hall. Coee break: Thursday 16th: ...............................................10:00 and 16:00

Lost and Found


Lost property can be found at the Exhibitor Support Centre.

Opening hours
Scientic sessions Wednesday 15th January (Pre Course room only) ...................................9:30 - 17:50 Thursday 16th January ......................................9:00 - 19:40 Friday 17th January ..............................................8:30 - 18:00 Saturday 18th January ........................................ 8:30 -14:00

Smoking
The entire Convention Center is a non-smoking area.

Tourism
You will nd a Singapore map and guide in your congress bag.

See you next year for the 6th edition!


Suntec International Convention &

22nd-24th January, 2015


Exhibition Centre - Singapore

www.asiapcr.com
AsiaPCR/SingLIVE 2014 - Programme 55